TSS:Rfhg 206028.1

Basic information about the TSS

---

TSS ID: rfhg_206028.1 Species: human Chr: chr19		Start: 3979372 End: 3979427 Strand: -
Source datasets	PRJNA615891
Protocol	TIF-seq2
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS (EH38D3035007,EH38E1933738)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000596417.1:-32 GeneID: 1938 HGNC/MGI_ID: HGNC:3214 UniProt_ID: Nearer transcript ids and distances: M19997:-487

Gene_name: eukaryotic translation elongation factor 2 Gene_symbol: EEF2 Gene_synonyms: EEF-2 Gene_source: HGNC:3214

TATA-Box annotation

---

Distance to TSS:	3173
Nearest PromoterID:	NR_002602
Entrez ID:	26812
Nearest Unigene:
Nearest Refseq:	NR_002602
Nearest Ensembl:	ENSG00000206775
Gene Name:	eukaryotic translation elongation factor 2
Gene Alias:	RNU37|U37
Gene Type:	snoRNA
CpG%:	0.109091
GC%:	0.660714
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EEF2 p3@EEF2 p4@EEF2 p5@EEF2 p6@EEF2 p7@EEF2 p8@EEF2 p10@EEF2
Sample		p1@EEF2	p3@EEF2	p4@EEF2	p5@EEF2	p6@EEF2	p7@EEF2	p8@EEF2	p10@EEF2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	2594.39	4.68	6.04	5.06	5.06	6.23	2.34	2.14
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	2695.49	3.24	5.06	6.88	3.24	3.64	2.83	3.24
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	2785.73	2.70	6.75	6.17	3.47	2.89	2.31	3.28
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	2471.22	2.08	4.99	5.61	3.53	4.16	2.29	2.49
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2553.37	3.60	5.40	3.60	1.35	4.50	4.05	2.47
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	2526.51	2.71	6.40	4.65	2.52	2.71	2.52	2.71
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	3096.56	4.36	9.15	9.37	4.14	4.14	2.61	4.36
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	2778.74	3.15	8.24	9.69	3.63	6.30	3.15	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	2843.29	2.78	9.40	5.77	4.06	3.85	4.49	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4333.29	4.64	5.80	8.69	5.80	12.75	2.90	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	4277.20	2.83	8.49	10.11	5.66	8.08	5.26	6.06
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	3526.84	4.88	6.10	8.13	5.69	4.07	2.44	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	1666.73	5.00	5.96	5.00	5.48	4.67	2.58	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	1631.45	4.36	7.52	5.71	5.11	4.96	2.10	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	1449.71	4.83	5.05	5.49	2.85	4.17	3.07	4.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	1616.33	8.30	9.81	6.54	4.53	4.28	2.77	3.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1622.55	3.71	4.37	5.90	4.37	2.84	2.18	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	1763.19	7.59	10.55	6.75	5.91	3.80	2.53	5.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	1769.01	3.20	4.80	8.00	8.00	3.20	3.20	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	1674.41	6.92	7.97	7.82	7.07	3.91	3.16	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	1748.43	6.42	7.62	6.28	6.82	4.01	2.41	3.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	1709.32	4.66	6.04	8.46	3.80	3.11	2.93	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	1632.90	5.17	8.27	7.24	4.14	5.30	2.33	2.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1567.15	5.34	5.34	4.13	4.37	5.34	6.31	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	1708.41	2.84	4.64	7.22	3.35	4.13	3.87	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	1646.81	4.11	5.70	2.85	5.70	4.75	2.85	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	1862.67	4.40	6.59	5.49	4.40	2.75	4.95	4.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	1825.20	2.36	3.30	5.66	4.72	2.83	1.65	2.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	1624.60	5.17	6.14	6.14	4.85	3.55	2.91	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	1534.41	4.52	5.97	4.71	3.98	3.62	4.16	3.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	1611.11	5.23	7.12	5.65	4.81	4.40	2.93	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	1604.67	4.49	4.88	7.23	5.08	2.15	3.91	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	1793.33	5.49	9.07	4.64	5.28	2.95	4.43	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	2167.97	5.11	9.90	6.76	4.62	4.29	2.80	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	1553.51	5.80	7.29	7.85	6.73	5.61	4.67	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	1476.27	4.79	6.13	4.79	4.41	2.87	4.41	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	1533.67	6.34	7.36	7.36	3.07	5.72	3.88	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	1562.93	4.23	7.66	7.86	6.04	4.03	2.62	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	1623.59	5.94	8.37	7.29	5.40	4.86	4.05	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	1409.88	4.56	6.00	6.96	4.56	3.60	2.88	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	1522.60	4.47	6.59	3.29	2.82	3.06	2.82	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1724.82	3.66	7.32	5.86	4.54	3.66	3.07	2.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	1315.76	5.69	6.96	6.33	7.17	5.06	3.16	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	1530.61	5.07	8.57	5.59	4.55	3.50	2.27	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	1375.70	4.22	5.22	7.03	3.81	5.42	5.22	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	1416.82	5.12	10.93	10.70	7.21	5.35	3.95	5.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	1502.53	3.60	3.60	5.76	5.76	4.56	2.88	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	1405.31	5.07	2.98	3.28	2.68	4.47	3.87	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	1491.78	3.11	5.03	5.51	5.74	3.11	4.55	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1522.54	2.83	4.85	4.65	6.27	3.84	4.04	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	1802.98	6.56	10.25	9.02	9.02	7.79	1.84	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	1809.68	7.34	7.56	7.12	9.56	5.78	4.23	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	727.59	27.98	0.00	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	2008.14	4.97	8.87	8.87	3.55	4.26	1.06	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	1760.64	3.31	7.62	7.95	6.30	5.63	1.33	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1268.47	9.23	10.07	6.71	7.55	10.91	1.68	7.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1928.36	5.51	6.43	8.27	5.05	8.73	4.13	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	1722.64	4.54	6.16	9.08	9.08	6.81	2.92	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1732.07	3.85	4.50	5.46	4.18	4.18	3.85	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1824.69	7.54	8.17	9.74	6.29	5.03	5.03	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	1704.12	4.94	8.46	7.05	3.53	4.23	2.82	4.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	1677.32	2.24	8.97	6.17	5.61	2.24	1.68	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	1107.43	22.29	8.76	3.98	11.94	7.17	4.78	8.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	1607.78	5.44	5.10	6.12	4.76	3.06	4.08	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	1520.31	4.87	4.22	5.85	5.85	2.60	1.95	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	1454.00	4.97	7.45	4.97	6.39	2.84	2.84	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	646.56	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	742.36	7.90	0.00	7.90	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	1336.28	1.46	5.85	4.39	4.88	3.90	1.95	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	1266.95	2.48	5.95	2.98	0.50	2.48	3.97	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	1319.15	1.88	3.28	2.81	5.63	2.35	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	1090.27	3.64	4.31	4.31	5.63	2.32	1.32	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	1156.01	3.40	5.57	5.57	4.64	2.17	2.47	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	1130.34	2.75	3.06	2.75	3.06	1.53	1.22	1.22
Adipocyte - breast, donor1	11376-118A8	1136.40	2.38	1.58	2.06	1.58	1.74	1.74	0.79
Adipocyte - breast, donor2	11327-117E4	1177.85	5.78	6.58	7.38	3.05	1.60	2.73	1.28
Adipocyte - omental, donor1	11473-119C6	1329.65	1.91	1.91	1.65	1.27	1.65	1.53	1.40
Adipocyte - omental, donor2	11474-119C7	1003.88	5.23	4.48	2.99	0.75	2.99	0.75	1.49
Adipocyte - omental, donor3	11475-119C8	1443.84	2.68	3.01	5.02	2.01	2.68	4.69	1.67
Adipocyte - perirenal, donor1	11476-119C9	1112.02	3.83	5.10	2.55	3.83	4.47	1.28	4.47
Adipocyte - subcutaneous, donor1	11259-116F8	1383.18	1.10	3.30	4.40	1.10	1.10	4.40	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	2344.83	0.45	1.81	1.81	1.81	3.61	9.48	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	4822.63	5.91	8.52	10.25	5.39	8.34	10.77	2.95
Adipocyte differentiation, day04, donor1	13019-139D4	901.00	1.76	0.98	1.17	0.59	1.37	0.39	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	681.03	3.09	1.80	1.03	1.29	0.51	1.03	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	865.03	1.39	1.67	0.56	1.39	2.51	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	697.14	0.59	0.59	1.18	1.76	2.35	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	1197.33	1.61	1.05	0.72	0.97	1.05	0.40	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	683.59	5.16	1.94	1.94	0.97	1.94	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	983.73	2.13	5.33	2.67	2.13	4.27	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	890.85	0.56	3.34	1.11	1.67	2.78	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	1103.78	2.08	0.83	1.66	2.50	1.25	2.08	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	702.51	1.26	1.76	0.75	1.51	1.76	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	888.47	2.62	1.64	1.31	1.31	1.64	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	549.27	0.61	1.22	0.61	0.30	0.61	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	1697.26	1.77	0.88	1.55	0.66	0.66	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	2126.39	3.59	5.38	4.30	2.15	2.87	2.51	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	1965.94	4.79	2.40	3.59	2.40	0.00	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	1944.60	1.80	2.16	1.44	0.72	0.90	0.36	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	2496.85	0.00	3.35	5.02	5.02	3.35	5.02	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	2079.13	2.47	2.67	2.88	1.85	1.85	1.23	0.82
Anulus Pulposus Cell, donor1	11248-116E6	2627.45	2.40	2.86	3.20	0.80	1.60	1.49	0.80
Anulus Pulposus Cell, donor2	11463-119B5	1808.64	0.98	4.65	1.71	1.47	1.47	2.20	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	1262.52	2.70	2.25	4.49	2.70	3.59	1.35	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	1482.16	2.17	4.34	3.47	4.34	1.30	1.30	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	1172.86	10.70	4.28	6.42	4.28	2.14	6.42	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	1263.84	2.09	5.08	4.78	2.69	1.49	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1460.67	5.06	8.85	7.59	6.32	2.53	1.26	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1256.11	2.64	1.32	3.96	0.66	2.64	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	1279.40	1.30	2.60	1.30	3.25	2.60	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	1347.10	3.88	2.91	3.40	0.49	0.00	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1387.89	8.91	6.53	7.72	4.16	1.78	2.97	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	1271.90	2.26	4.52	6.40	3.39	1.88	0.38	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	1232.92	2.18	2.18	4.35	2.18	0.00	1.45	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1112.10	1.25	5.02	6.27	5.02	2.51	3.76	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	1359.24	1.15	0.99	1.32	0.99	0.82	0.33	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1074.10	1.36	0.00	2.73	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	973.81	1.96	1.96	0.75	1.96	2.11	0.15	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1289.64	1.07	3.21	3.75	3.21	1.61	1.07	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	1140.23	3.40	4.35	2.08	2.65	2.08	1.70	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	1376.26	4.28	4.01	1.87	3.21	1.60	2.14	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1033.00	2.93	2.93	5.85	1.95	2.93	2.93	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	1136.63	1.33	3.65	2.82	1.66	1.33	1.00	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1187.51	2.40	3.60	1.20	3.60	4.80	1.20	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	934.60	0.00	3.54	7.08	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	1156.63	3.95	2.92	2.40	1.37	1.03	0.69	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	1304.63	4.19	0.00	0.00	0.00	4.19	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	1469.38	3.88	4.37	5.34	3.88	6.31	1.46	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	1297.34	3.42	1.90	1.90	1.52	1.90	0.76	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1349.46	8.48	8.48	2.42	7.27	6.06	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	1219.30	2.28	2.85	1.71	2.28	0.57	1.71	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	1275.81	1.92	2.14	2.57	0.86	2.35	2.14	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	1209.93	2.06	2.06	2.84	2.06	2.58	0.52	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	1260.29	3.28	5.63	3.28	2.82	0.47	0.94	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	1126.39	1.29	1.29	5.79	0.64	1.29	0.96	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	1240.69	2.85	2.85	2.14	6.42	3.57	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1137.15	1.75	4.09	4.68	2.34	1.75	0.58	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	1185.92	1.20	2.41	3.31	2.41	0.90	1.81	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	1306.79	3.56	5.94	8.32	7.13	0.00	0.00	5.94
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	1397.52	3.56	3.05	3.56	4.07	2.03	2.03	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	1186.85	4.58	5.60	4.08	2.80	1.78	2.29	3.06
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1170.98	2.54	1.27	3.81	1.91	2.54	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	1302.80	2.59	3.02	3.88	2.16	0.00	2.59	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	1087.64	2.96	3.18	4.02	1.27	1.06	1.06	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	1079.60	3.19	2.61	4.06	1.45	0.87	2.03	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	1268.78	0.94	1.89	1.89	2.83	1.89	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	1120.90	2.20	2.54	2.71	2.54	0.85	1.70	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	1445.41	6.95	0.00	6.95	4.63	2.32	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	931.64	4.23	4.23	4.23	0.00	4.23	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	1200.71	1.93	2.79	2.36	1.29	1.93	0.86	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	1314.03	3.01	4.21	3.61	4.21	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	1257.49	2.19	5.83	4.37	1.46	2.19	1.46	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	1344.34	2.07	2.07	4.60	1.84	0.69	0.92	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	1461.32	17.85	7.65	2.55	7.65	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	977.52	1.78	2.54	1.27	0.51	1.53	0.51	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	1327.61	3.92	2.68	3.72	1.65	1.86	1.65	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	1328.35	3.06	1.53	1.53	1.53	3.06	0.31	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1382.41	3.82	6.69	3.35	1.43	1.91	1.91	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	1257.27	3.99	3.55	2.88	1.33	1.33	1.55	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1203.85	3.05	4.58	7.63	1.53	9.15	1.53	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1236.83	3.88	4.43	2.22	2.22	1.11	1.11	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	1225.20	1.32	2.38	3.18	2.12	1.85	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1300.41	3.27	3.27	2.91	1.45	0.73	1.09	1.45
Astrocyte - cerebellum, donor1	11500-119F6	2656.89	1.23	1.47	1.35	1.11	1.23	0.86	2.09
Astrocyte - cerebellum, donor2	11580-120F5	2227.82	2.57	2.91	4.28	1.71	1.54	2.05	1.20
Astrocyte - cerebellum, donor3	11661-122F5	2871.23	4.61	4.82	3.57	2.94	3.36	1.68	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	1688.20	1.74	1.05	1.39	1.05	0.00	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	1502.23	6.15	3.07	4.37	2.59	1.94	1.46	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	1310.82	2.83	3.28	1.19	1.94	2.24	1.94	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	1869.03	4.59	4.82	2.64	1.49	2.18	1.72	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1839.64	3.26	2.26	3.51	1.50	1.25	1.00	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1736.54	3.41	2.73	3.53	1.14	1.59	1.02	0.46
Basophils, donor1	12241-129G9	1077.51	0.78	0.52	1.05	1.31	0.78	0.00	0.26
Basophils, donor2	12242-129H1	1204.69	1.44	0.72	1.08	0.72	0.36	0.00	0.00
Basophils, donor3	12243-129H2	1172.16	1.76	0.15	0.59	0.15	0.73	0.29	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	2643.94	3.02	3.23	2.37	3.02	0.22	2.59	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	2938.79	2.74	5.49	3.20	0.91	3.20	2.74	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	2044.47	0.00	14.35	0.00	0.00	0.00	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	1387.74	1.88	1.26	3.77	1.26	2.51	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	2197.20	2.91	3.33	2.91	2.08	2.08	1.46	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	2816.91	3.22	6.45	6.68	9.21	7.14	2.07	3.45
Bronchial Epithelial Cell, donor7	11769-123I5	1525.03	3.96	4.32	4.32	0.54	1.08	1.62	1.80
Burkitt's lymphoma cell line:DAUDI	10422-106C8	3010.35	2.89	2.47	2.37	2.47	1.55	1.13	1.75
Burkitt's lymphoma cell line:RAJI	10476-106I8	3217.57	3.96	4.89	2.56	1.63	1.86	1.86	2.79
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	2295.34	3.52	1.92	1.28	2.24	0.64	2.24	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	3381.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1012.15	0.56	1.69	0.00	0.56	1.13	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	1194.90	3.90	2.41	2.97	1.11	0.74	0.74	0.74
CD14+ Monocytes, donor3	11381-118B4	981.99	3.07	1.76	2.20	1.32	1.54	1.10	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	921.87	1.98	0.57	1.70	0.85	0.28	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	918.88	1.52	0.38	0.76	1.14	1.90	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	942.83	1.97	1.31	0.99	0.33	0.99	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	1110.28	2.31	3.18	2.02	2.31	2.17	0.87	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	938.12	1.81	1.51	0.91	3.32	1.81	0.00	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	854.47	2.13	3.08	1.66	1.42	1.42	1.18	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	944.46	2.68	1.51	1.84	2.34	2.51	0.67	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	861.98	3.31	1.93	2.76	1.66	1.66	0.28	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	907.92	1.74	2.23	1.98	2.23	0.99	1.74	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	923.20	3.52	2.15	1.76	1.76	1.96	1.17	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	937.78	2.85	0.89	1.60	1.96	1.60	1.25	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	982.38	1.09	1.52	1.52	1.96	0.65	1.09	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1098.29	1.64	2.34	2.81	1.87	1.17	0.70	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1357.56	2.11	0.53	2.64	2.11	2.11	2.11	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1377.82	4.44	1.11	5.55	2.22	2.22	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1090.62	3.42	1.19	2.97	3.12	3.12	1.78	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	886.39	3.19	0.80	3.19	1.60	2.59	0.80	2.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	778.67	1.25	2.08	0.42	0.62	1.46	0.62	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1171.61	3.43	3.20	1.60	2.06	2.97	0.69	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1042.12	1.58	1.13	1.36	2.71	1.36	0.00	2.26
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	894.74	1.31	1.75	2.18	0.87	1.75	1.31	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	933.39	2.69	1.88	1.61	3.23	3.77	0.81	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1135.21	3.66	2.79	2.09	1.57	1.92	1.57	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	994.82	1.26	1.68	2.52	2.10	3.37	1.68	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1033.56	2.76	3.12	2.39	1.47	1.29	0.73	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	893.70	2.82	3.87	1.76	1.41	1.41	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	901.58	2.63	0.88	0.88	1.75	1.32	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	887.04	2.62	2.09	1.92	2.09	2.09	0.87	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	889.42	2.60	2.23	3.35	1.86	0.74	0.74	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1084.43	3.02	0.65	1.51	1.72	1.29	1.08	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	970.90	2.87	2.05	2.87	4.09	1.23	1.64	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	964.52	2.55	1.16	1.16	1.62	1.39	0.46	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	866.95	2.55	1.86	1.39	1.39	1.16	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	812.57	1.09	1.31	0.44	2.83	2.18	1.09	1.74
CD14+CD16+ Monocytes, donor2	11801-124D1	1096.30	2.77	1.39	2.54	1.85	1.39	1.15	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	619.52	0.87	1.30	0.43	1.30	0.00	0.22	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	1539.47	1.87	2.02	2.02	1.71	1.87	0.62	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	1411.65	1.57	0.52	2.10	2.45	1.40	0.70	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	938.25	0.45	0.45	0.22	1.78	0.67	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	737.20	1.53	1.79	1.79	1.02	1.28	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	924.81	2.20	1.32	1.10	1.10	1.32	0.66	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	701.54	0.42	0.21	0.42	0.84	0.63	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	1532.36	0.00	4.06	0.00	6.10	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	1682.06	6.10	2.03	2.03	2.03	2.03	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1780.19	2.07	4.14	2.07	4.14	3.11	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1858.17	2.67	1.60	3.20	1.07	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	2497.00	3.75	0.54	4.82	6.43	1.61	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	1675.53	1.40	1.40	0.70	3.51	2.11	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1797.74	1.57	2.35	0.00	4.71	1.57	2.35	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1721.68	2.64	2.64	1.32	3.95	1.32	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	2383.51	7.40	3.29	3.29	4.11	1.64	2.47	4.11
CD19+ B Cells, donor2	11624-122B4	2416.40	6.53	0.73	4.35	5.08	1.45	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	2113.20	0.50	3.53	4.04	4.04	2.52	2.02	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1154.80	0.40	0.40	0.00	0.81	1.21	0.40	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	842.13	1.60	0.80	0.40	1.20	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	1841.42	4.02	4.02	1.00	3.01	3.01	1.00	4.02
CD34+ Progenitors, donor2	11625-122B5	1887.67	1.12	1.69	1.69	0.56	0.56	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1790.47	4.51	1.88	4.13	1.13	0.75	0.75	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	2159.45	2.03	1.13	1.35	2.03	1.13	0.45	0.68
CD4+ T Cells, donor1	11225-116C1	2474.40	2.14	2.14	1.43	1.79	1.07	1.79	0.36
CD4+ T Cells, donor2	11306-117C1	2464.76	13.47	12.25	7.96	3.67	4.29	4.29	7.35
CD4+ T Cells, donor3	11382-118B5	2360.34	6.40	7.01	6.10	3.66	2.74	1.22	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1592.68	2.04	1.79	1.79	3.06	3.06	0.26	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1951.53	2.02	2.92	2.02	3.37	2.02	1.12	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1861.31	2.30	3.16	1.72	1.15	2.59	0.29	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2253.35	3.79	3.32	4.27	2.37	2.84	0.47	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2493.94	5.62	3.51	2.81	4.92	1.40	0.00	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	2218.36	6.59	3.30	6.59	0.00	3.30	6.59	9.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	1537.64	2.75	2.46	2.75	3.32	3.47	0.87	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	1359.60	1.69	2.20	2.71	1.53	1.02	1.19	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	1059.12	2.26	2.58	1.45	1.61	0.97	0.97	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1480.28	4.48	3.59	2.24	4.03	1.79	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1770.35	3.49	2.10	2.45	2.10	2.45	1.05	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1823.28	2.20	2.20	2.64	2.64	1.76	0.88	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	1772.58	0.42	0.84	0.84	2.11	1.26	0.84	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	1135.05	2.91	2.91	1.45	2.49	1.45	0.83	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	1130.69	2.67	2.34	1.34	2.34	5.01	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2863.74	4.08	4.08	4.08	5.71	4.08	1.09	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2641.16	1.61	2.14	2.68	2.14	5.90	1.61	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	2255.88	5.38	3.59	10.76	1.79	3.59	7.17	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	1614.15	1.11	1.85	1.48	2.23	1.11	0.56	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1266.78	2.17	1.73	1.73	2.38	1.52	0.43	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	1162.35	2.10	1.47	1.89	2.10	1.89	0.63	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1822.20	6.07	2.02	2.02	4.04	3.03	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1905.01	1.30	2.17	0.87	0.43	2.60	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1857.01	3.05	3.05	3.49	2.18	2.61	0.87	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	2157.13	1.98	2.47	0.99	1.48	2.47	1.98	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1557.41	1.85	0.92	0.00	2.77	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1309.28	2.79	0.00	0.00	1.40	0.00	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	2516.45	0.28	1.11	1.38	1.11	1.66	1.11	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	2593.78	1.47	0.49	1.47	2.70	2.70	1.23	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1903.45	1.54	3.08	1.54	1.54	1.54	0.00	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	2237.88	1.79	3.22	1.43	2.15	2.51	1.07	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1772.79	1.38	1.38	0.00	1.38	2.77	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	1788.89	1.96	2.62	0.98	1.64	0.65	1.64	0.98
CD8+ T Cells, donor2	11307-117C2	1469.82	9.01	6.38	3.38	3.38	3.38	2.25	2.25
CD8+ T Cells, donor3	11383-118B6	1913.62	5.05	4.54	2.78	3.53	2.78	2.02	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1215.32	1.38	3.90	3.90	1.38	1.84	2.06	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1178.56	2.16	2.16	3.59	1.44	0.48	1.20	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1193.13	1.64	1.64	4.65	3.01	0.82	1.37	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1426.30	2.10	1.80	3.90	3.30	0.90	1.20	2.40
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	1293.03	1.92	4.32	7.44	0.96	0.96	1.68	2.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	1189.00	0.91	0.68	3.18	2.05	1.59	1.36	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1072.51	0.65	2.39	3.91	0.87	0.87	1.09	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1118.62	1.84	4.21	4.21	1.84	0.53	0.26	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1089.56	0.94	3.52	3.75	1.41	0.47	1.64	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1237.70	1.21	5.43	3.02	2.11	0.91	2.72	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	1149.53	0.87	3.78	6.39	1.45	1.74	3.20	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	1136.61	2.66	2.40	3.20	2.40	1.87	1.60	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	980.12	0.00	1.31	1.31	0.44	0.88	0.88	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	902.21	1.37	3.19	1.37	1.37	2.28	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	682.47	0.00	2.98	2.98	0.75	0.75	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1317.45	1.80	2.16	3.60	1.80	1.08	1.44	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	1166.71	2.01	2.59	3.74	1.15	0.86	1.73	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1081.61	0.94	2.83	3.30	1.41	0.24	0.94	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1093.64	1.27	4.75	3.49	0.63	1.90	0.95	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	1066.01	2.46	1.54	2.46	1.54	0.92	0.31	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	966.56	0.96	3.21	2.89	0.96	0.96	0.32	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1152.37	1.15	3.44	4.97	1.91	1.15	1.15	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	1059.75	1.97	1.58	0.79	0.39	1.58	1.18	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	1068.81	0.76	3.03	2.27	0.00	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	990.05	0.80	0.80	4.01	0.80	0.00	0.80	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	961.71	0.70	0.00	2.80	2.80	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	986.72	2.00	1.00	2.00	0.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	689.06	3.66	1.83	9.14	5.48	3.66	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	1535.14	1.48	2.47	2.96	0.99	1.98	2.47	0.49
Cardiac Myocyte, donor3	11686-122I3	1969.22	1.79	1.26	1.26	0.42	0.11	0.42	0.21
Chondrocyte - de diff, donor1	11261-116G1	1480.96	0.69	1.73	4.51	0.00	0.35	2.43	1.04
Chondrocyte - de diff, donor2	11338-117F6	2887.79	2.13	3.91	2.84	3.91	1.42	2.49	2.13
Chondrocyte - de diff, donor3	11410-118E6	2183.42	3.87	4.89	5.46	2.05	1.82	8.76	1.02
Chondrocyte - re diff, donor2	11339-117F7	1321.40	2.69	2.69	1.79	3.58	3.58	1.79	3.58
Chondrocyte - re diff, donor3	11411-118E7	1499.53	4.85	6.87	4.85	4.45	2.43	2.02	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	1722.29	3.90	2.07	2.41	1.61	1.84	1.03	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	1672.07	6.20	6.41	2.78	2.99	1.71	1.07	2.35
Ciliary Epithelial Cells, donor3	11399-118D4	1636.68	4.07	3.19	1.95	1.15	2.12	1.24	1.59
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	1515.99	1.74	1.65	2.11	1.10	1.28	1.10	0.55
Corneal Epithelial Cells, donor1	11526-119I5	2507.08	2.85	1.98	1.10	1.32	0.88	2.20	1.54
Corneal Epithelial Cells, donor2	11606-120I4	1773.52	3.41	2.28	1.14	1.14	2.28	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1631.69	3.83	4.60	4.35	2.56	1.02	1.28	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	464.74	0.66	1.16	0.17	0.33	0.33	0.17	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	436.53	1.58	0.00	0.00	0.32	0.32	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	445.14	3.45	0.00	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	457.23	1.84	1.08	1.08	0.76	1.19	0.65	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1571.21	3.76	1.37	0.68	1.37	1.02	1.02	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1275.71	0.00	1.31	0.65	1.31	0.65	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1355.53	1.94	0.97	0.48	0.97	1.45	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	2552.73	3.17	3.00	1.00	1.00	0.67	1.50	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	1493.93	0.59	1.76	3.52	2.93	1.76	2.93	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	1690.56	1.41	1.98	1.13	1.13	1.13	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	2109.43	4.72	2.75	2.75	1.97	0.79	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	1364.49	0.29	2.33	1.45	2.33	1.45	2.33	0.29
Endothelial Cells - Artery, donor2	11341-117F9	1663.65	1.65	6.82	8.47	0.47	0.47	1.41	0.24
Endothelial Cells - Artery, donor3	11413-118E9	2241.50	4.38	3.68	3.86	2.10	3.86	3.51	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	1401.73	1.99	3.77	1.77	2.22	1.99	1.33	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	1101.45	1.52	0.91	0.30	1.83	2.74	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	1101.40	1.69	1.13	1.13	0.56	0.85	0.56	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	2110.54	1.49	2.38	1.78	0.00	2.08	5.05	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	2030.59	1.04	1.56	0.52	1.04	0.52	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	1961.05	3.97	4.82	7.80	1.56	1.84	3.69	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	1592.88	1.20	1.60	1.60	0.80	1.20	0.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	1496.38	1.57	7.86	4.72	1.57	0.52	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1619.80	2.86	2.36	1.37	1.86	2.61	0.99	1.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	761.50	1.09	1.52	0.87	0.65	0.65	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	838.28	1.47	1.47	0.98	1.59	1.59	0.49	0.24
Endothelial Cells - Vein, donor1	11267-116G7	1541.32	1.14	3.41	2.28	2.28	1.14	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	2275.02	2.79	2.79	2.10	2.10	0.70	0.70	1.40
Endothelial Cells - Vein, donor3	11416-118F3	1665.84	3.93	2.67	2.20	2.98	2.51	1.73	1.57
Eosinophils, donor1	12244-129H3	1509.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	430.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	331.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2178.90	1.71	0.98	1.47	1.47	1.22	0.73	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	2947.59	4.16	6.24	8.32	8.32	0.00	10.40	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	1496.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	1196.24	2.87	1.23	2.05	2.46	2.87	1.23	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	769.05	8.21	8.65	5.15	5.26	8.10	6.24	5.15
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	1466.79	3.03	7.91	7.80	3.14	2.71	4.12	2.71
Fibroblast - Aortic Adventitial, donor1	11245-116E3	1618.72	2.30	2.43	3.27	1.58	2.18	1.82	1.70
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1223.60	1.36	1.23	1.09	0.14	0.27	0.41	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	1703.85	4.32	4.22	4.75	1.79	2.95	3.59	2.85
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	1045.27	0.26	0.79	1.32	1.05	1.84	1.58	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	1216.85	1.99	0.66	5.32	3.32	1.66	1.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	1403.07	4.08	3.18	3.63	3.18	1.81	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	3096.98	3.79	7.58	4.55	1.52	2.27	0.76	2.27
Fibroblast - Cardiac, donor3	11417-118F4	1539.63	1.58	5.36	5.84	1.58	2.21	2.84	1.26
Fibroblast - Cardiac, donor4	11452-119A3	1698.01	0.61	1.21	0.30	0.91	1.52	1.82	1.21
Fibroblast - Cardiac, donor5	11456-119A7	1501.28	1.78	2.03	1.78	2.54	2.41	1.78	1.40
Fibroblast - Cardiac, donor6	11460-119B2	1101.63	2.12	1.52	2.27	1.97	2.27	1.67	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	3277.41	1.88	2.68	1.74	1.74	1.47	1.07	1.74
Fibroblast - Choroid Plexus, donor2	11572-120E6	1985.43	1.29	1.73	2.16	1.73	2.16	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	1756.29	0.00	1.46	1.46	0.00	1.46	1.46	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	2739.07	3.23	2.08	2.31	0.46	1.38	1.15	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	4817.44	3.56	3.90	3.56	2.54	2.54	1.70	0.51
Fibroblast - Dermal, donor1	11269-116G9	1795.37	2.58	2.58	3.29	1.64	1.88	7.51	0.94
Fibroblast - Dermal, donor2	11346-117G5	2516.41	2.36	2.36	0.47	0.94	1.89	0.94	1.42
Fibroblast - Dermal, donor3	11418-118F5	2255.25	4.35	4.35	5.20	3.02	2.90	4.11	1.33
Fibroblast - Dermal, donor4	11450-119A1	1535.95	1.92	3.05	1.81	1.81	2.03	1.47	1.02
Fibroblast - Dermal, donor5	11454-119A5	1552.63	1.74	1.74	1.74	3.66	2.09	0.87	1.57
Fibroblast - Dermal, donor6	11458-119A9	1616.92	1.79	1.79	2.92	2.11	1.46	0.97	1.62
Fibroblast - Gingival, donor1	11237-116D4	1713.73	2.71	1.25	1.46	0.83	0.42	0.42	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	1385.19	1.57	3.41	1.31	3.41	2.88	0.79	2.10
Fibroblast - Gingival, donor2	11318-117D4	1382.68	3.29	4.09	4.48	1.84	0.79	1.98	1.05
Fibroblast - Gingival, donor3	11394-118C8	2501.19	2.71	2.32	2.80	2.03	2.80	1.26	1.84
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	1194.73	3.12	2.08	3.12	4.16	3.12	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	1181.97	2.64	4.58	2.11	3.70	2.11	1.59	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	1237.04	1.71	1.56	1.09	1.56	1.40	1.71	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	1235.17	2.16	2.43	1.35	2.03	2.30	0.54	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	957.01	0.71	0.71	0.35	0.35	1.41	0.71	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	1126.23	2.19	1.17	0.88	2.05	1.32	0.58	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	1110.33	1.09	1.36	0.27	0.68	2.18	0.41	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	1072.47	1.86	1.86	1.32	2.63	1.32	0.77	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	1784.34	3.96	3.52	2.20	3.52	8.07	1.61	1.47
Fibroblast - Lung, donor1	11270-116H1	1879.98	1.36	1.36	2.72	2.72	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	1766.71	1.49	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	1621.81	2.11	5.70	6.54	1.27	1.90	1.90	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	4306.72	0.83	2.50	1.67	0.83	0.83	1.67	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	2506.34	0.00	1.40	2.80	1.40	0.00	4.20	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	2419.81	1.96	4.20	2.80	2.24	1.96	1.40	1.68
Fibroblast - Mammary, donor1	11540-120B1	3307.83	2.44	2.44	0.41	0.81	0.00	1.22	2.03
Fibroblast - Mammary, donor2	11620-122A9	2760.00	11.98	7.99	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	2960.26	0.00	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	1619.10	2.13	1.94	2.13	0.58	1.94	0.39	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	1586.44	2.58	2.88	3.03	1.37	1.21	0.91	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1366.23	0.00	0.31	0.61	1.53	0.00	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	868.19	1.91	1.53	0.76	1.91	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	1279.21	2.70	3.78	2.43	1.35	2.43	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	1068.24	1.39	1.74	1.39	1.74	2.55	0.58	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	1151.86	1.77	1.99	1.88	0.44	0.44	0.55	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	2164.79	2.64	2.84	1.83	1.42	1.02	1.63	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2284.59	4.01	5.35	3.34	2.67	2.00	2.00	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	1825.78	3.56	2.77	3.56	0.79	0.79	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1747.13	0.79	1.98	2.58	1.39	0.40	0.60	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	2236.92	2.49	2.13	1.95	2.66	1.78	1.42	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	2009.28	2.96	1.18	1.77	0.79	1.97	1.18	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1488.93	1.20	2.41	1.20	1.20	1.81	0.90	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1921.11	1.19	1.94	2.59	2.37	2.27	1.40	1.73
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	1360.02	0.76	2.02	1.27	1.27	0.51	0.25	1.27
Fibroblast - skin normal, donor1	11553-120C5	1994.04	2.13	1.64	1.97	0.66	1.64	1.97	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1363.05	2.21	0.60	1.20	0.80	0.40	0.60	1.20
Fibroblast - skin normal, donor2	11561-120D4	1521.70	0.60	1.71	1.31	1.71	1.00	0.60	1.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	1749.65	0.91	1.51	2.72	3.02	1.21	1.21	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	2551.49	3.23	1.66	2.24	2.57	1.82	0.99	1.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	3251.48	3.08	4.44	5.47	4.62	3.42	1.88	3.08
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1028.98	0.66	0.66	2.30	0.00	0.00	1.97	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1329.92	0.96	1.81	1.17	1.38	0.75	0.64	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	1369.52	1.52	1.35	1.69	0.84	0.00	1.01	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1603.17	4.86	7.06	8.63	1.10	2.35	4.55	1.57
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	576.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	993.54	2.61	3.49	0.87	2.61	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	974.27	1.73	1.21	1.04	1.21	0.69	0.52	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1083.64	2.34	0.78	1.04	1.30	1.04	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	792.09	0.77	1.28	0.26	0.51	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	2217.80	5.36	4.59	6.89	4.59	5.36	4.59	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	2410.00	7.66	12.12	10.85	6.38	8.29	8.29	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	2113.23	5.71	4.85	2.00	4.85	9.98	3.42	3.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1587.26	2.76	4.41	4.96	10.75	9.65	4.14	10.75
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	1004.18	2.74	1.37	2.97	6.16	7.31	2.28	2.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1720.76	3.76	3.37	3.17	4.76	5.75	2.38	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1439.83	4.76	2.64	3.17	8.99	11.10	7.67	10.04
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	927.89	2.61	1.63	2.28	4.89	2.94	1.30	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	2044.84	1.77	2.21	4.42	3.54	7.52	2.65	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	2776.84	2.54	5.79	4.52	2.40	2.40	1.98	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	2169.40	2.71	3.20	2.71	3.45	2.83	1.97	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1775.08	2.15	4.30	5.10	1.07	1.34	1.61	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	1954.79	2.23	3.59	2.97	1.49	2.73	2.11	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	2391.87	2.35	2.35	3.46	3.32	2.77	1.94	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	1486.55	1.63	3.46	3.25	3.25	1.42	1.02	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	1451.90	2.97	5.25	1.83	0.91	2.05	2.74	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	2161.46	2.49	2.74	2.12	2.37	1.74	2.49	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	1522.60	1.31	3.06	1.75	2.62	2.19	2.19	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	1656.16	1.18	4.14	2.66	1.18	2.36	2.07	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	2065.82	1.91	2.70	3.50	1.75	3.34	1.75	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	1468.98	1.79	2.01	3.35	1.12	2.46	1.56	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	1537.25	3.02	2.42	4.03	1.01	2.22	1.81	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	1696.76	1.70	2.54	3.05	1.53	1.70	1.53	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	1770.61	0.80	1.42	2.13	1.15	1.77	1.51	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2371.85	1.25	1.98	2.71	0.94	1.35	2.50	2.19
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2115.23	1.37	3.76	2.73	1.20	2.39	2.56	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1930.69	1.22	2.66	1.66	1.44	1.55	1.77	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	1571.16	0.67	1.00	1.58	0.42	1.00	1.00	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	1463.57	1.43	1.43	1.63	1.02	1.23	1.84	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	1469.31	1.24	4.54	4.54	1.86	1.44	1.24	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	2180.31	1.38	2.65	1.61	2.31	3.11	1.96	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	1221.72	2.17	2.33	3.50	0.67	2.33	1.83	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	1462.56	1.32	1.76	3.97	2.20	1.76	4.19	2.20
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	2384.08	4.06	3.32	4.06	2.46	3.07	1.35	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	1258.97	1.30	1.46	1.78	1.13	1.46	0.81	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	1827.75	2.25	4.17	5.77	0.64	2.57	1.60	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	1770.58	1.80	3.22	1.99	1.42	1.61	1.61	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	1346.24	1.11	1.74	1.74	1.58	1.42	0.79	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	1256.49	1.82	2.74	3.34	0.91	0.61	2.43	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	1406.98	0.84	3.14	2.40	1.88	1.57	1.36	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	1357.29	2.20	1.76	2.42	1.76	2.20	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	1223.19	2.52	1.40	3.09	1.40	1.96	3.09	2.52
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	1140.58	1.02	1.02	1.02	1.85	1.48	0.83	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	995.28	1.07	3.21	3.21	0.80	1.87	1.34	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	855.45	0.92	1.53	1.84	0.31	0.77	0.77	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	1211.17	1.17	2.20	1.30	0.65	0.78	0.65	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	1207.63	1.90	2.71	2.71	1.08	1.36	1.08	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	1223.91	1.66	2.77	2.95	1.29	1.29	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	1420.93	1.97	3.95	3.73	1.10	1.97	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	1364.64	0.99	2.98	0.99	0.00	1.98	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	1201.98	0.53	1.85	1.71	0.92	0.53	1.06	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	1259.57	2.62	3.03	2.42	1.01	0.61	1.01	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	1608.32	0.76	1.27	0.25	0.51	0.25	0.25	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2730.31	3.18	2.39	3.18	2.39	3.98	2.39	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	2882.46	4.93	5.39	4.01	2.77	5.08	2.77	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	3634.00	3.27	2.86	3.27	3.89	3.68	0.82	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1634.75	2.82	2.19	1.88	2.19	2.19	1.88	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1699.01	2.83	2.54	3.96	2.54	3.39	1.70	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1692.16	4.61	5.53	3.23	5.53	3.23	3.23	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1541.80	7.42	7.42	7.42	7.42	4.95	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1472.58	4.64	4.64	4.64	1.93	5.80	5.03	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1227.42	4.81	6.42	4.81	1.60	1.60	6.42	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1646.67	6.96	8.69	8.69	3.48	3.48	5.22	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1242.68	1.95	5.21	3.91	1.95	4.23	3.25	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1395.18	3.29	7.41	3.29	0.41	4.94	4.53	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	1529.51	13.33	10.00	13.33	16.66	6.66	26.66	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1231.85	0.56	3.08	4.47	1.40	3.64	4.47	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1422.42	3.92	3.60	3.27	1.63	3.92	3.27	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1557.72	2.52	4.19	7.55	1.68	5.87	6.71	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1528.97	3.50	4.13	3.50	3.50	5.41	4.77	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1450.70	3.06	6.45	6.79	3.06	3.06	2.72	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	1409.50	6.26	0.00	4.18	2.09	4.18	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1935.15	1.72	4.01	6.30	2.29	2.86	3.44	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1642.41	2.07	4.44	4.14	2.37	2.37	2.96	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1204.54	3.39	1.69	5.08	1.69	1.69	6.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1330.43	2.90	6.63	3.31	1.66	2.90	2.07	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1223.14	2.30	5.75	3.91	1.15	2.76	4.37	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	1243.36	5.27	5.27	5.27	0.00	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1215.51	2.69	5.38	6.92	1.54	2.69	3.08	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1230.21	2.93	6.19	3.26	1.63	3.59	2.93	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1187.86	6.69	2.68	2.01	6.69	6.69	3.34	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	2036.14	2.70	7.32	8.48	1.16	8.09	3.85	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	1684.31	3.77	2.74	5.48	3.77	1.37	5.48	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	1816.38	9.94	2.48	4.97	4.97	7.45	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1917.13	6.61	3.77	5.66	4.25	7.55	9.44	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1827.98	1.81	7.24	6.03	4.22	8.45	3.02	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	2015.37	5.09	5.09	5.60	7.63	4.07	7.12	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1807.54	4.39	7.18	8.77	1.60	3.99	4.79	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	1804.20	6.91	5.92	6.91	0.99	4.44	5.92	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	1411.81	10.62	8.26	8.26	5.90	4.72	8.26	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	1802.27	5.25	7.58	3.50	2.92	4.08	4.67	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1991.21	9.22	5.27	3.95	6.14	4.83	4.39	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	1448.71	10.17	4.24	3.39	0.85	3.39	3.39	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1021.92	6.57	4.18	5.97	1.19	2.39	5.37	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1136.45	1.46	6.31	3.88	2.91	3.88	4.37	4.37
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	1369.56	2.28	0.00	2.28	3.42	2.28	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	1422.09	2.08	4.99	6.65	2.08	0.83	1.66	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1972.29	4.50	2.25	1.12	0.00	5.62	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	2822.42	4.12	6.34	7.61	1.27	1.90	3.49	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2266.25	2.51	6.68	4.60	0.84	1.67	2.51	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	944.58	1.86	3.37	2.79	1.16	0.35	1.04	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	977.53	2.19	2.19	1.18	1.52	0.68	1.35	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	962.79	0.68	1.14	2.50	1.37	0.46	0.91	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	984.76	2.73	2.62	3.50	0.66	1.20	0.87	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	979.35	1.50	2.79	1.93	0.43	0.21	0.86	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	871.03	1.94	1.51	1.51	1.08	1.08	1.08	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	937.77	1.99	2.12	2.62	1.12	0.62	0.25	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	843.51	0.86	2.23	2.57	1.20	1.03	1.03	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	841.94	0.96	2.56	2.24	0.64	0.64	0.96	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	1548.48	2.24	1.68	1.12	2.80	1.12	3.36	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2316.31	3.46	2.60	0.43	2.16	1.73	1.30	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	912.11	5.29	7.93	7.93	0.00	0.00	5.29	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	2434.13	2.47	3.17	1.76	1.06	0.71	0.71	3.17
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2572.58	2.18	4.36	2.91	3.63	2.91	2.91	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	1068.79	2.45	3.15	2.62	0.87	0.17	2.10	0.87
Hepatocyte, donor1	11523-119I2	1041.12	3.63	4.84	1.21	2.42	3.63	1.21	0.00
Hepatocyte, donor2	11603-120I1	1119.35	4.31	7.54	2.15	0.00	2.15	2.15	3.23
Hepatocyte, donor3	11684-122I1	855.89	1.23	1.84	0.00	1.23	2.45	0.61	4.91
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1434.60	4.57	5.22	1.96	3.26	0.65	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	1315.41	3.15	1.75	1.05	0.87	1.05	0.87	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	1408.02	0.96	0.96	1.37	0.82	0.41	0.41	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	1502.80	3.18	6.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	1702.20	6.68	0.00	13.35	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1083.33	54.17	0.00	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1697.24	1.38	9.69	2.77	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2044.68	5.01	2.50	5.01	2.50	5.01	5.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	2373.65	0.00	0.00	0.00	11.87	0.00	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	1881.17	2.56	0.00	2.56	2.56	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	2161.97	0.00	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1739.66	4.87	11.37	6.50	0.00	4.87	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1782.35	0.00	6.67	5.00	1.67	0.00	3.33	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	1804.39	7.26	7.26	18.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1835.65	2.65	2.65	5.29	0.00	3.97	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1728.38	1.11	3.33	6.65	0.00	1.11	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	2236.75	0.00	0.00	5.24	0.00	5.24	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	2088.00	2.52	4.41	3.78	1.89	0.63	1.26	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1840.48	4.64	0.00	4.64	0.00	3.09	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	1331.76	0.00	0.00	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	2316.69	5.17	8.40	2.58	1.94	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1989.87	0.00	3.22	3.22	0.00	1.61	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	1660.80	11.95	35.84	11.95	11.95	0.00	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	2201.80	4.07	4.89	0.81	3.26	4.07	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2496.61	2.52	1.26	1.26	2.52	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	1250.40	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	2336.31	2.41	4.82	3.21	2.41	0.80	3.21	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1883.49	1.85	5.54	7.39	1.85	3.69	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	1221.54	0.00	15.08	0.00	15.08	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2127.94	3.78	4.72	3.30	3.30	1.42	1.89	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1614.43	2.72	2.72	8.16	1.81	1.81	3.63	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	1430.02	0.00	14.74	14.74	14.74	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	2478.30	6.46	7.53	1.08	5.38	4.30	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2258.88	1.27	2.54	3.81	2.54	0.00	2.54	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	1692.33	16.43	0.00	0.00	0.00	0.00	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2679.53	2.55	6.38	3.83	3.19	0.00	3.83	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1970.30	0.00	3.65	3.65	1.82	0.00	3.65	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	1122.11	0.00	15.80	0.00	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2691.31	5.00	7.14	5.71	2.86	3.57	4.28	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	1871.53	0.00	3.32	3.32	6.64	0.00	9.95	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	979.88	0.00	0.00	0.00	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	2298.90	2.16	4.01	4.32	2.16	2.47	1.23	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1836.80	0.00	5.27	8.78	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	1879.59	3.14	9.43	3.14	3.14	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2129.28	2.09	4.87	3.48	4.17	4.87	1.39	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2133.42	4.43	4.43	2.21	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	1909.55	3.24	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	2358.57	0.87	3.49	2.62	0.87	4.36	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	1687.34	0.00	6.75	2.25	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	1658.66	0.00	3.48	6.97	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2467.45	4.27	5.33	3.20	4.27	4.27	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1604.34	0.00	0.00	5.54	2.77	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	1453.30	0.00	0.00	0.00	0.00	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	2352.61	2.76	7.36	3.68	0.92	2.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	1875.70	6.05	6.05	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	1626.67	0.00	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2957.47	1.06	11.63	8.46	1.06	2.11	0.00	2.11
Keratinocyte - epidermal, donor1	11272-116H3	1687.88	1.88	2.28	2.04	1.31	1.39	1.39	1.31
Keratinocyte - epidermal, donor2	11349-117G8	2769.47	1.76	0.59	1.17	1.76	1.76	1.76	0.59
Keratinocyte - epidermal, donor3	11421-118F8	1198.63	1.23	2.37	2.75	0.85	0.76	1.61	0.85
Keratinocyte - oral, donor1	11251-116E9	3404.73	2.61	3.52	3.75	1.36	1.59	1.36	1.14
Keratocytes, donor1	11527-119I6	1625.29	2.06	1.03	1.03	1.72	0.34	0.34	0.34
Keratocytes, donor2	11607-120I5	2061.20	3.52	4.69	1.17	3.52	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	1314.61	1.19	1.38	1.38	1.38	1.38	1.58	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	85.72	0.00	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	1367.85	1.08	2.16	3.24	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	2157.40	1.50	1.04	1.27	0.46	0.69	0.46	0.35
Lens Epithelial Cells, donor3	11690-122I7	1955.93	0.30	1.31	0.30	0.40	0.61	0.50	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	1896.99	2.61	3.56	2.61	1.66	1.54	1.54	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	1465.14	3.07	2.51	2.23	1.12	1.12	0.56	1.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	1652.51	2.99	4.09	4.09	2.83	3.15	2.68	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	1316.33	2.15	2.15	0.54	0.54	2.15	0.00	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	1547.78	6.93	6.62	2.84	4.10	2.52	1.58	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1603.95	3.02	3.88	3.13	2.48	1.94	2.59	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	1299.30	3.28	2.87	2.05	1.23	1.64	0.82	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1735.35	2.02	4.05	2.78	1.26	0.76	1.26	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	1590.20	2.67	3.24	3.94	1.27	2.67	2.96	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	1097.60	1.58	3.16	3.96	0.40	0.40	0.00	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	1430.67	2.33	3.10	1.55	1.36	1.55	1.16	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1729.84	2.96	5.37	2.22	1.85	1.85	3.15	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	1329.93	1.39	3.48	2.44	1.74	1.39	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	1676.82	3.82	5.25	2.86	0.48	1.67	2.39	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	1627.99	2.20	3.43	2.88	0.27	2.06	0.96	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	1234.91	0.62	2.16	1.85	1.23	0.62	1.54	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1554.04	2.49	4.36	2.81	1.56	1.56	1.56	1.56
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	1938.97	1.83	2.01	1.83	1.28	1.10	2.56	1.83
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	1376.01	1.65	2.63	1.32	1.32	1.65	1.97	2.30
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	1877.31	2.34	3.51	4.98	1.17	1.46	2.05	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2071.83	3.24	4.23	4.48	2.74	3.24	4.48	3.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	1251.69	1.94	2.42	1.45	0.97	1.45	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	1362.37	2.15	1.89	1.62	1.89	0.54	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	1707.54	2.72	4.69	3.94	2.12	2.42	2.12	2.12
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	1229.67	1.04	3.11	2.59	2.07	0.52	1.04	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	1358.53	1.68	2.09	2.51	1.05	0.84	1.47	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	1732.13	2.56	2.86	3.61	1.95	1.95	2.41	1.35
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	1231.30	2.06	2.06	4.13	1.38	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	1339.05	1.51	3.01	1.88	1.13	1.51	1.13	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1803.67	2.12	3.82	3.92	1.17	1.70	2.12	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	1210.47	1.45	1.94	2.91	2.42	0.00	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	1285.45	1.65	1.32	2.65	2.32	0.99	1.98	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1805.60	2.97	3.10	4.71	2.35	1.49	1.73	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	1304.62	2.22	1.48	1.85	1.85	0.74	2.59	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	1278.90	1.24	1.98	2.22	1.98	0.74	1.73	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1800.07	3.44	4.12	3.16	1.51	1.10	2.20	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	1270.15	0.64	2.89	1.93	1.61	0.32	2.25	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	1350.31	2.13	2.74	4.56	0.30	0.30	3.04	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	1588.06	2.94	2.38	4.06	0.98	2.10	0.98	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	1250.86	2.84	3.91	2.13	1.42	1.78	1.42	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1403.43	0.48	1.94	0.97	1.94	0.48	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1984.15	4.05	3.58	2.65	1.24	2.96	2.80	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	1157.40	1.07	2.51	1.07	1.43	1.43	1.43	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	1284.48	1.31	1.63	1.63	1.31	1.96	1.31	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1697.17	4.00	4.71	4.00	2.12	1.18	2.35	1.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	1710.25	2.35	2.10	1.61	0.99	1.61	1.61	1.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1365.67	2.31	2.82	1.79	0.51	0.51	1.79	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	1457.17	3.28	3.28	5.37	0.90	1.19	3.58	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	1830.94	2.27	0.00	0.00	4.53	2.27	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1793.56	4.60	5.37	6.14	3.84	3.84	3.07	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1514.14	1.48	4.45	3.71	1.48	1.48	0.74	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	2090.26	6.35	5.50	9.73	8.89	5.92	2.54	4.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1834.27	8.44	7.74	7.03	3.52	0.70	2.11	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1657.79	2.80	3.74	0.93	4.67	1.87	5.60	4.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	1963.69	7.21	14.94	7.21	5.67	8.24	5.15	6.18
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1636.70	7.14	5.95	7.14	7.14	3.57	3.57	5.95
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2070.80	2.04	3.39	2.94	1.36	1.58	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	1800.22	3.78	7.85	8.43	3.49	4.07	1.74	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1764.68	9.90	5.85	8.55	0.90	5.40	2.25	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	2743.73	3.52	2.44	3.66	2.71	3.25	2.17	2.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	1991.44	5.14	11.30	6.68	4.62	4.62	2.57	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1653.48	3.18	3.88	6.35	2.12	1.76	3.18	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1561.82	2.67	4.00	3.33	1.33	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	1809.34	8.15	9.17	7.64	4.08	2.55	4.58	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1790.00	5.87	5.87	5.34	2.67	2.67	4.80	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1965.59	3.02	6.61	6.61	4.91	5.10	2.08	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	1868.91	6.75	10.43	4.91	4.29	7.36	6.14	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	1908.09	8.15	7.34	16.31	7.34	4.08	2.45	5.71
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1944.99	11.04	8.54	7.91	7.50	5.00	2.92	3.75
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1934.36	8.13	11.49	10.37	3.64	7.01	6.73	5.89
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1859.77	7.21	14.42	8.24	3.09	4.12	5.15	6.18
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1877.11	8.42	11.90	10.45	6.97	8.71	8.13	6.97
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	1738.58	3.29	5.08	8.67	3.89	2.39	1.79	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1579.55	6.09	3.32	6.64	3.32	5.53	2.77	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	2122.34	12.02	9.19	9.90	3.89	7.42	4.24	5.66
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	1885.57	8.11	9.59	6.27	3.32	1.84	3.32	2.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	1639.42	9.21	10.36	4.61	2.30	4.61	2.30	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	2012.02	6.91	8.44	7.68	3.84	6.91	2.69	3.84
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	1969.00	12.45	14.15	10.19	4.53	5.66	3.40	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	1709.04	3.28	2.46	2.46	1.64	1.64	1.64	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	1884.35	7.23	7.68	8.13	2.71	1.81	3.62	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	1984.23	5.03	9.34	6.46	7.18	5.03	3.59	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1882.20	1.49	6.72	3.73	3.73	2.24	3.73	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	2136.29	3.72	6.69	8.18	6.69	7.06	5.20	6.32
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	1775.97	3.88	5.17	9.91	3.88	1.72	4.74	5.17
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	1743.42	4.28	5.99	5.99	3.43	4.28	4.28	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1990.40	7.00	7.33	7.33	3.00	1.67	5.66	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1863.62	3.02	10.86	6.64	5.43	5.43	7.84	4.83
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	1626.05	3.55	2.13	5.69	5.69	1.42	4.27	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1829.95	7.22	6.53	5.84	3.44	5.16	2.75	4.81
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1911.36	4.83	7.51	6.98	6.44	3.76	6.98	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	1581.05	6.73	4.71	5.39	1.35	2.69	3.37	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	2063.17	10.00	8.89	11.11	7.04	4.82	6.30	4.44
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	1729.28	3.49	0.00	3.49	5.81	10.47	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	1518.92	2.12	1.06	8.46	0.00	1.06	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	1947.13	2.00	8.80	7.20	3.60	5.60	4.80	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	1720.51	3.63	6.54	5.09	0.73	0.73	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1743.06	5.37	6.13	7.67	4.60	2.30	3.07	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	2002.21	7.40	10.36	8.88	2.47	7.89	4.93	4.93
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1774.60	9.41	8.47	7.53	0.00	1.88	2.82	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1797.08	5.53	5.03	7.54	3.52	4.02	3.52	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1998.52	9.01	5.41	7.66	5.41	3.15	3.15	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1820.93	3.44	15.49	13.77	8.61	5.16	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1885.58	5.34	8.46	8.02	4.01	4.45	3.56	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	2061.88	8.60	9.78	5.87	4.69	4.69	3.91	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	1770.73	6.60	9.24	7.92	5.28	3.96	1.98	4.62
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1739.96	5.19	5.71	5.19	4.15	4.67	4.15	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	2171.64	6.13	6.13	11.81	5.25	7.00	5.69	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1859.01	6.15	5.59	9.50	6.71	4.47	5.03	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	1738.74	5.74	4.86	4.86	2.21	3.97	5.30	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1967.53	6.17	7.33	8.87	5.40	4.63	3.47	5.79
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1893.77	8.10	6.08	8.61	3.54	2.53	2.03	5.57
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1732.63	6.73	9.61	4.81	5.77	4.33	1.92	3.84
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	2015.16	5.57	7.95	9.94	5.96	3.58	5.96	5.17
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	1967.48	6.68	6.68	5.47	5.47	4.86	4.86	4.25
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1790.12	4.15	6.23	3.46	3.46	3.46	2.08	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	2110.09	6.46	8.74	6.46	4.56	3.80	4.56	4.18
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1990.79	9.81	7.23	9.81	4.65	4.65	6.20	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	2044.94	2.42	10.28	4.84	7.26	4.23	0.60	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1953.38	7.29	12.04	6.34	4.75	4.44	3.49	3.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	1990.02	4.80	6.93	7.46	3.73	0.53	2.13	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2018.24	4.60	5.75	4.02	6.90	5.17	2.30	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	2249.77	7.71	9.77	12.34	6.69	9.77	3.60	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	2188.55	9.20	5.66	7.78	3.54	2.12	6.37	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2229.09	3.97	6.81	6.24	2.84	4.54	2.84	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	2126.72	6.66	7.90	7.07	4.16	5.82	4.99	5.41
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	2279.43	3.92	5.48	8.61	8.61	3.13	6.26	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2122.81	5.01	5.85	8.77	2.51	2.09	3.34	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	2073.68	5.58	8.83	9.76	4.65	3.25	3.72	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	1886.05	5.35	12.04	6.02	4.01	2.68	6.02	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	2185.62	2.67	6.42	5.35	4.81	2.67	1.60	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	2107.76	7.27	10.10	10.10	6.87	4.85	6.47	3.64
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	1831.85	6.42	6.42	5.51	0.92	4.59	7.34	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	1919.59	3.56	7.11	8.00	4.45	3.56	6.22	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	1973.46	2.28	7.98	5.70	2.85	2.85	3.42	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	1825.99	3.07	9.20	5.37	4.60	2.30	3.07	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	1934.82	4.38	5.47	6.02	3.28	2.19	1.64	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1819.21	4.45	5.35	3.56	4.45	2.23	2.67	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2217.42	2.86	1.82	2.86	2.86	2.08	1.30	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	1974.07	7.96	5.97	3.32	2.65	3.32	3.32	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	1893.61	6.24	6.24	8.31	4.16	4.16	4.16	4.16
Macrophage - monocyte derived, donor1	11232-116C8	416.40	0.46	0.91	0.68	0.23	0.91	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	358.21	0.00	0.18	0.00	0.00	0.55	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	432.04	1.18	0.66	0.52	0.66	0.52	0.79	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	541.64	1.59	1.06	0.53	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	912.53	0.32	0.32	1.43	0.48	0.32	0.48	0.32
Mallassez-derived cells, donor3	11930-125I4	1175.56	0.83	0.97	1.25	0.83	0.83	0.00	0.42
Mammary Epithelial Cell, donor1	11273-116H4	1771.46	1.00	1.69	0.90	0.60	0.50	0.60	0.60
Mammary Epithelial Cell, donor2	11350-117G9	1699.37	0.87	3.47	1.74	0.58	0.00	1.16	0.00
Mammary Epithelial Cell, donor3	11422-118F9	1766.19	3.49	2.00	2.74	2.00	2.24	1.25	1.50
Mast cell - stimulated, donor1	11487-119E2	1021.65	1.36	3.39	2.71	0.68	1.36	2.03	2.71
Mast cell, donor1	11563-120D6	1042.91	1.41	0.65	1.19	0.87	1.73	0.76	1.51
Mast cell, donor2	11565-120D8	1130.75	0.59	2.08	0.59	2.38	4.16	0.59	0.89
Mast cell, donor3	11566-120D9	988.75	1.13	1.35	1.13	2.03	3.60	2.70	0.45
Mast cell, donor4	11567-120E1	1037.85	0.53	0.71	0.35	1.42	2.30	2.13	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	895.02	1.66	0.89	0.55	0.55	0.78	0.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	1185.46	1.17	1.75	1.17	1.75	5.25	2.33	2.33
Mast cell, expanded, donor5	11939-126A4	732.50	1.03	1.03	1.03	1.26	1.03	0.57	1.61
Mast cell, expanded, donor8	11941-126A6	1122.36	1.84	1.51	1.51	2.18	5.36	1.00	2.18
Melanocyte - dark, donor1	11502-119F8	1654.85	1.59	2.19	1.29	0.20	0.60	0.60	0.60
Melanocyte - dark, donor2	11582-120F7	1543.18	1.04	3.81	1.73	1.04	1.73	2.08	1.38
Melanocyte - dark, donor3	11663-122F7	918.98	0.51	0.22	0.29	0.14	0.29	0.22	0.14
Melanocyte - light, donor1	11274-116H5	1379.17	3.29	2.59	1.18	1.65	2.12	2.12	1.18
Melanocyte - light, donor2	11351-117H1	1876.78	7.51	2.73	0.00	1.36	2.73	5.46	2.73
Melanocyte - light, donor3	11423-118G1	1427.45	10.41	6.94	6.94	7.81	2.60	2.60	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	936.82	0.94	2.08	2.71	0.94	1.15	0.73	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	899.88	2.15	2.69	1.88	1.08	1.34	1.08	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	1044.63	1.34	0.80	1.61	0.80	0.80	0.80	0.54
Meningeal Cells, donor1	11493-119E8	2495.21	0.87	1.61	0.37	0.87	1.12	0.25	0.50
Meningeal Cells, donor2	11573-120E7	1879.87	1.76	2.20	2.20	0.00	1.76	1.76	0.88
Meningeal Cells, donor3	11654-122E7	1648.13	1.14	1.63	1.55	0.73	0.33	0.49	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	1655.62	2.00	1.43	0.86	1.14	0.86	0.29	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	1436.12	2.11	1.11	1.41	1.31	0.81	0.50	0.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5721.87	1.31	3.94	6.57	1.31	5.26	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2633.33	1.31	5.23	1.31	3.92	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	1358.43	4.31	2.87	0.72	1.44	1.44	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	1757.89	2.54	2.12	2.75	0.64	1.48	1.69	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	1288.28	5.03	5.03	2.01	1.51	2.01	3.52	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	2062.60	1.54	0.66	1.10	1.32	2.42	0.44	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1769.48	2.92	3.65	2.19	3.65	2.19	2.92	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	1814.01	3.48	2.66	2.46	3.07	2.66	2.05	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	3213.37	2.22	1.80	1.80	1.11	2.63	1.66	1.52
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3247.75	2.97	2.60	3.35	2.23	2.23	1.49	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	3506.45	3.16	3.55	2.89	2.37	2.24	0.92	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5829.16	6.23	6.53	4.75	3.86	1.78	2.37	2.97
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4561.32	14.01	7.01	4.67	7.01	2.34	4.67	7.01
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	2074.90	3.20	4.48	3.20	2.56	0.00	1.92	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	1447.91	1.06	1.42	1.06	0.00	0.71	0.71	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	3094.09	1.56	3.44	5.63	0.94	1.56	1.25	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	1301.89	2.18	1.45	6.53	0.00	0.73	2.18	1.45
Mesothelial Cells, donor1	11247-116E5	831.32	1.33	2.65	0.80	0.53	0.80	1.06	1.06
Mesothelial Cells, donor2	12156-128G5	768.22	0.50	0.00	1.00	0.50	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	867.25	2.31	0.94	1.52	0.87	0.94	0.94	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	228.20	0.00	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	454.38	0.74	0.49	0.49	0.49	0.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	477.61	0.88	0.59	0.29	0.59	0.29	0.88	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	210.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	400.45	0.93	0.93	0.00	0.00	1.24	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	399.31	0.41	0.41	0.21	0.21	0.21	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	115.80	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	458.48	1.00	0.75	0.50	0.50	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	359.82	0.47	0.47	0.93	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	420.25	1.02	1.22	0.61	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	421.70	0.00	0.79	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	499.10	0.88	0.88	1.77	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	493.54	1.52	1.14	0.38	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	160.54	1.32	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	474.75	0.64	1.27	0.85	0.21	0.64	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	195.21	0.92	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	319.81	0.60	0.00	0.60	0.00	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	145.87	0.00	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	410.98	2.26	1.00	1.76	0.25	0.50	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	327.51	1.43	0.48	0.48	0.71	0.48	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	211.75	0.00	1.11	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	345.83	0.23	0.69	0.92	0.46	0.92	0.23	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	360.94	0.84	0.00	0.21	0.21	0.63	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	374.02	0.61	0.20	0.20	0.61	0.61	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	374.59	0.64	0.86	0.43	0.43	0.43	0.43	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	278.53	0.44	0.44	0.22	0.44	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	113.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	324.36	0.44	0.00	0.00	0.22	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	175.91	1.01	0.51	0.00	0.00	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	159.07	3.31	4.97	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	278.59	1.09	0.54	0.27	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	316.73	0.00	0.88	0.00	0.29	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	159.19	4.36	4.36	0.00	1.09	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	356.57	0.48	1.44	1.44	0.96	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	372.21	2.40	0.80	0.00	0.80	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	123.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	413.98	0.50	2.00	1.50	1.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	404.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	79.50	0.00	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	323.19	0.44	0.88	1.31	0.00	0.44	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	120.30	0.00	0.00	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	115.27	0.64	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	342.62	0.50	0.74	0.25	0.00	0.50	0.25	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	148.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	123.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	291.62	0.00	0.34	1.71	0.68	1.37	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	170.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	150.56	0.36	0.36	0.00	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	328.25	0.84	0.56	0.00	0.00	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	200.75	0.00	0.42	0.00	0.83	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	109.56	0.00	0.00	0.00	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	223.53	0.00	0.60	0.60	0.90	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	255.86	0.00	1.67	0.42	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	218.88	0.92	0.00	0.92	0.00	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	239.03	2.28	2.85	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	238.36	0.14	0.14	0.28	0.28	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	263.55	0.00	0.78	0.26	0.26	0.52	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	202.48	0.00	1.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	90.83	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	170.81	0.00	0.80	0.27	0.27	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	225.39	0.00	0.00	0.30	0.90	0.30	0.00	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	190.83	0.42	0.14	0.00	0.00	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	231.24	0.96	0.96	0.64	0.32	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	240.37	0.00	0.88	0.22	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	138.03	0.38	1.14	0.00	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	202.00	0.57	0.00	0.57	0.28	0.57	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	312.17	0.49	0.49	0.49	0.25	0.00	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	64.52	0.00	0.65	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	172.30	0.29	0.29	0.29	0.29	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	244.50	0.00	0.29	0.58	0.29	0.58	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	207.72	0.00	0.00	1.24	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	176.88	0.00	0.30	0.00	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	241.08	0.00	3.77	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	418.83	0.00	0.00	0.00	1.78	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	517.17	1.64	1.64	0.66	0.99	0.66	0.33	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	360.82	0.00	1.05	0.00	1.05	1.05	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	385.09	0.79	0.59	0.79	0.20	0.40	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	583.01	0.93	0.93	0.00	1.86	2.79	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	520.86	1.88	0.75	1.88	0.75	0.38	0.75	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	366.22	0.53	1.33	1.07	1.60	0.53	1.07	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	303.90	0.57	0.45	0.11	0.23	0.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	554.75	1.47	3.68	2.21	0.74	0.74	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	446.30	0.37	1.10	1.83	1.10	0.37	1.10	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	378.01	9.33	4.67	3.11	1.56	3.11	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	162.47	0.00	0.53	0.00	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	506.17	0.00	3.86	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	600.91	1.01	1.01	3.03	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	183.41	0.00	0.84	0.42	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	145.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	64.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	70.46	0.00	0.00	0.81	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	98.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	1279.08	0.00	0.00	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	884.12	0.00	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	437.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	966.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	1411.32	1.72	2.15	0.86	0.65	1.29	1.08	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	1649.89	2.61	6.79	3.66	3.14	2.61	1.05	3.66
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	527.98	0.00	0.67	0.00	0.67	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	280.47	2.09	1.67	0.00	1.25	0.83	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	522.13	2.09	1.71	0.57	1.90	1.33	1.33	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	346.30	0.00	3.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	463.72	2.72	4.08	2.04	2.04	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	288.51	3.68	0.00	0.00	0.00	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	648.73	1.26	2.51	1.67	2.51	2.51	2.93	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	534.84	0.93	1.16	1.86	1.16	0.46	2.09	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	630.98	2.16	0.54	0.00	2.16	2.43	1.89	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	652.36	0.63	0.42	0.21	1.05	0.84	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	579.01	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	1062.20	0.99	4.96	0.50	2.98	3.47	2.48	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	897.81	5.41	2.98	1.35	2.98	1.08	1.62	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	843.94	3.85	1.59	1.59	2.95	3.63	1.81	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	771.27	1.63	2.45	1.14	2.78	2.45	1.63	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	809.03	1.82	1.64	1.09	4.01	1.64	0.91	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	1235.39	3.71	3.18	2.12	6.37	3.18	2.12	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	941.88	3.00	4.80	1.20	5.40	4.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	989.78	6.89	3.94	0.98	5.25	4.27	2.30	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	799.46	2.11	2.76	2.44	2.28	1.46	2.44	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	644.85	1.23	1.23	0.35	0.53	1.94	0.18	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	1229.95	2.11	4.22	4.92	4.22	2.81	2.81	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1090.89	2.76	4.14	3.22	3.22	2.30	1.84	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	1051.76	3.21	2.89	1.61	4.18	2.89	1.61	2.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	1018.45	8.62	7.93	3.45	5.86	3.79	2.76	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	594.18	10.11	5.06	0.00	2.53	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	602.41	1.78	2.01	1.34	2.01	0.67	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	936.54	6.35	4.23	5.50	2.54	1.27	1.69	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	804.15	2.61	3.09	2.85	4.27	2.37	0.95	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	1172.28	2.15	2.58	2.15	1.29	1.72	2.58	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	604.86	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	1091.30	2.33	2.67	2.00	3.67	2.00	4.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	492.79	1.80	0.45	0.90	0.00	0.00	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	827.33	0.79	3.57	1.59	1.98	1.19	1.98	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	886.86	3.71	1.86	4.64	4.64	1.86	3.71	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	950.09	1.51	1.14	2.27	6.81	1.14	3.03	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	694.79	1.30	4.89	3.58	6.52	2.28	2.28	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	779.62	5.67	1.74	1.74	1.74	1.74	4.36	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	499.32	2.71	1.81	0.00	1.36	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	969.22	0.00	1.76	2.65	0.88	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	1175.45	3.32	1.33	1.99	3.32	3.32	1.99	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	1173.14	4.46	4.46	0.99	1.49	3.97	0.99	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	668.03	2.68	1.91	1.53	1.91	3.06	1.91	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	1368.27	2.72	5.44	6.05	3.93	1.81	4.84	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	732.69	0.66	0.66	0.44	1.77	1.33	1.11	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	1053.75	4.74	3.39	3.39	1.36	3.39	3.39	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	444.53	15.33	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	1202.90	0.00	3.05	3.66	2.44	3.66	2.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	675.42	2.83	2.83	1.89	2.52	2.52	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	863.17	8.17	11.80	6.36	2.42	4.54	2.42	3.63
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	1143.20	6.33	6.33	0.00	5.54	4.75	3.16	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	783.35	19.27	4.53	4.53	9.07	4.53	3.40	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	348.99	5.06	0.00	0.00	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	944.76	1.74	1.74	1.37	0.75	0.87	0.62	1.37
Myoblast, donor2	11322-117D8	1473.32	9.21	4.22	4.60	3.26	2.11	2.88	1.92
Myoblast, donor3	11398-118D3	1031.34	2.02	1.18	0.17	0.67	0.50	0.17	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	1936.53	2.63	1.75	2.19	1.75	2.04	1.31	1.17
Natural Killer Cells, donor1	11230-116C6	1486.54	2.15	0.31	0.62	1.85	0.31	2.15	0.62
Natural Killer Cells, donor2	11311-117C6	1417.31	5.13	2.11	3.02	1.21	1.81	1.51	1.81
Natural Killer Cells, donor3	11387-118C1	1334.94	3.87	1.66	2.58	2.02	1.47	1.10	1.10
Neural stem cells, donor1	11275-116H6	1808.53	1.45	2.54	1.09	1.09	0.73	0.36	1.09
Neural stem cells, donor2	11352-117H2	1573.25	1.93	0.00	0.00	0.00	1.93	1.93	3.85
Neurons, donor1	11494-119E9	1434.89	1.14	3.41	1.14	0.00	1.14	0.00	1.14
Neurons, donor2	11574-120E8	1364.79	1.32	1.76	1.10	0.22	0.44	0.22	0.44
Neurons, donor3	11655-122E8	969.33	3.29	9.04	6.58	2.47	2.47	2.47	1.64
Neutrophils, donor1	11233-116C9	129.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	168.13	0.00	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	142.94	0.61	0.00	0.00	0.61	0.61	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	3828.27	2.26	3.32	5.34	0.83	1.66	1.66	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	2322.85	3.26	4.56	5.21	3.58	3.91	2.28	2.93
Nucleus Pulposus Cell, donor3	11462-119B4	2180.20	1.00	2.81	3.81	2.21	3.41	1.80	1.60
Olfactory epithelial cells, donor1	11933-125I7	1437.50	4.54	5.64	4.68	2.48	2.34	2.89	1.51
Olfactory epithelial cells, donor2	11934-125I8	1385.36	6.22	7.38	5.79	2.46	2.75	3.47	1.45
Olfactory epithelial cells, donor3	11935-125I9	1547.53	4.54	4.09	3.75	1.25	1.82	1.59	1.36
Olfactory epithelial cells, donor4	11936-126A1	1809.64	3.70	3.02	2.53	2.82	1.95	1.75	1.85
Oligodendrocyte - precursors, donor1	11496-119F2	1548.48	1.20	0.00	1.81	1.81	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	4368.10	2.34	3.83	2.77	5.53	3.19	1.49	5.10
Osteoblast - differentiated, donor2	11353-117H3	1343.16	11.43	0.00	9.14	14.86	0.00	2.29	6.86
Osteoblast - differentiated, donor3	11425-118G3	1752.89	2.48	3.10	5.59	1.24	5.59	5.59	3.72
Osteoblast, donor1	11277-116H8	3283.93	3.52	2.74	1.17	3.32	0.98	0.78	1.56
Osteoblast, donor2	11354-117H4	1516.30	2.11	0.70	2.11	0.00	3.51	0.00	0.70
Osteoblast, donor3	11426-118G4	2145.92	4.98	4.09	3.55	3.91	2.84	1.96	1.24
Pancreatic stromal cells, donor1	11249-116E7	1639.81	2.36	2.61	2.53	0.93	1.77	1.68	0.93
Pericytes, donor1	11491-119E6	3448.26	1.56	1.89	1.67	2.34	3.34	1.89	1.45
Pericytes, donor2	11571-120E5	2623.13	3.17	4.30	5.21	2.72	2.72	3.17	0.68
Pericytes, donor3	11652-122E5	2636.51	6.92	8.95	4.07	4.88	1.83	3.87	3.46
Perineurial Cells, donor1	11499-119F5	1835.69	1.02	1.13	0.79	1.02	0.57	0.45	0.11
Perineurial Cells, donor2	11579-120F4	2025.16	1.10	1.20	1.38	1.01	0.74	0.64	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	1709.40	0.00	2.55	0.96	0.64	0.64	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1204.72	3.43	3.18	1.96	2.20	1.71	1.71	2.94
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1448.94	4.53	2.59	1.68	2.07	1.94	0.52	0.78
Placental Epithelial Cells, donor1	11278-116H9	1116.67	0.72	1.20	0.72	0.24	0.48	0.24	0.96
Placental Epithelial Cells, donor2	11355-117H5	2322.01	2.22	4.44	6.65	1.11	1.11	3.33	0.00
Placental Epithelial Cells, donor3	11427-118G5	2084.21	3.73	4.91	4.52	1.18	1.57	4.12	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	859.48	3.16	7.28	4.75	1.58	2.53	2.53	1.90
Preadipocyte - breast, donor1	11467-119B9	1453.24	1.69	2.25	1.69	1.50	1.13	0.75	1.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	1034.30	1.44	0.78	0.65	0.26	0.26	0.52	0.39
Preadipocyte - breast, donor2	11328-117E5	1495.21	4.73	7.43	5.85	3.60	3.38	3.38	2.93
Preadipocyte - omental, donor1	11468-119C1	1397.41	2.24	1.07	1.39	2.66	2.88	1.07	0.75
Preadipocyte - omental, donor2	11329-117E6	984.24	0.44	2.18	1.31	0.44	1.31	0.87	1.31
Preadipocyte - omental, donor3	11403-118D8	1106.88	3.01	2.58	2.58	1.00	1.43	1.72	2.29
Preadipocyte - perirenal, donor1	11469-119C2	1336.64	2.95	2.95	4.92	3.94	3.94	4.92	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	2733.35	2.15	2.15	1.84	1.54	2.76	1.54	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	1473.28	1.59	3.36	4.78	0.53	0.71	1.06	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	1728.56	2.21	4.94	6.47	1.53	1.53	4.09	0.85
Preadipocyte - visceral, donor1	11280-116I2	1702.08	1.49	0.65	1.12	0.93	0.56	1.68	0.65
Preadipocyte - visceral, donor2	11357-117H7	1276.54	2.76	5.52	0.92	0.92	0.46	2.30	0.00
Preadipocyte - visceral, donor3	11429-118G7	1103.11	0.94	3.13	3.24	0.94	1.67	1.99	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	1748.68	2.56	2.72	2.26	1.51	3.92	2.26	1.81
Prostate Epithelial Cells, donor2	11331-117E8	782.55	2.57	2.71	3.11	1.76	1.49	1.35	1.35
Prostate Epithelial Cells, donor3	11404-118D9	1279.31	3.98	2.82	3.06	1.84	1.90	2.08	1.29
Prostate Stromal Cells, donor1	11254-116F3	1640.51	2.05	3.19	2.39	1.59	0.57	1.37	1.59
Prostate Stromal Cells, donor2	11332-117E9	1523.50	5.02	3.94	5.56	1.97	1.08	2.51	2.87
Prostate Stromal Cells, donor3	11405-118E1	1841.93	6.36	5.21	5.84	3.65	3.13	3.55	2.92
Renal Cortical Epithelial Cells, donor1	11516-119H4	2574.59	1.46	1.82	0.36	1.82	0.73	2.19	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	1574.83	1.25	1.52	1.18	0.49	0.49	0.83	0.62
Renal Epithelial Cells, donor1	11517-119H5	2937.37	1.52	1.01	0.51	0.00	1.01	0.51	2.03
Renal Epithelial Cells, donor2	11597-120H4	1826.67	1.42	3.56	2.13	1.42	2.85	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	1960.40	2.22	2.33	0.95	0.74	0.85	1.06	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1527.15	1.36	4.09	4.09	2.04	2.72	0.00	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	1465.29	1.48	2.02	2.02	2.02	1.75	0.67	1.75
Renal Glomerular Endothelial Cells, donor3	11675-122H1	1001.49	2.00	2.22	1.78	2.00	1.55	0.67	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1704.20	2.00	3.33	2.00	1.33	3.33	4.66	2.66
Renal Mesangial Cells, donor1	11518-119H6	2191.20	1.76	2.42	0.88	0.88	1.10	0.66	1.76
Renal Mesangial Cells, donor2	11598-120H5	2138.02	4.39	3.13	3.76	1.88	1.88	3.13	1.88
Renal Mesangial Cells, donor3	11679-122H5	2247.03	1.94	2.22	3.05	2.22	0.55	1.66	2.50
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	1793.06	0.81	2.42	1.07	0.27	0.00	0.54	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	1568.70	1.27	2.11	1.27	3.80	0.84	2.53	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	1883.15	3.28	3.28	1.93	2.31	0.96	1.74	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	2245.64	2.59	2.07	2.07	0.78	0.52	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3129.81	3.13	2.56	4.55	3.98	1.71	1.71	2.84
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1823.61	2.06	5.15	3.09	3.09	2.06	3.09	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3493.89	2.26	3.51	2.26	0.75	2.51	2.51	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	1408.79	1.74	1.60	1.07	1.34	2.00	1.07	2.81
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	687.92	0.00	3.57	1.79	0.89	0.00	2.68	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1738.07	3.30	0.55	3.85	2.20	1.10	0.55	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1045.84	2.32	1.74	0.00	2.90	1.74	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	850.10	0.65	0.65	0.65	0.26	0.26	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	934.17	1.79	1.19	1.19	0.40	0.50	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	1033.19	1.34	1.00	0.89	0.78	0.22	0.33	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	1132.51	1.24	1.12	1.24	0.99	0.62	0.74	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	995.41	2.56	2.10	1.98	1.28	1.05	0.47	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	1048.64	2.54	0.46	0.92	0.92	1.16	0.69	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	776.41	0.41	0.55	0.14	0.55	0.68	0.14	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	948.79	2.12	1.51	1.51	1.66	1.51	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	899.00	1.43	0.72	0.18	0.54	0.36	0.18	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	931.18	0.57	0.29	1.58	0.43	0.57	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	974.95	1.40	0.86	1.61	0.75	0.43	0.64	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	950.57	0.89	1.55	1.77	0.89	0.66	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	726.09	0.00	0.57	0.19	0.96	0.57	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	834.09	0.93	1.02	0.28	0.65	0.37	0.28	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	1232.29	1.13	0.19	0.56	0.75	0.75	0.56	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	799.43	0.53	0.80	0.00	1.06	0.40	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	851.05	1.36	0.68	1.17	1.07	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	1012.85	2.67	1.53	1.91	0.57	0.57	0.19	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	840.68	0.64	0.85	0.75	0.32	0.53	0.21	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	945.75	4.48	3.64	2.80	1.96	0.84	0.84	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	833.64	1.54	1.37	0.51	0.34	0.68	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	788.03	0.91	0.91	0.73	1.09	0.18	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	916.55	1.10	1.23	1.47	0.74	0.12	0.37	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	1024.32	0.94	1.21	1.61	1.48	0.67	0.94	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	951.04	0.47	1.18	1.18	1.42	1.18	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	931.15	1.98	2.58	1.59	0.99	0.99	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	1035.24	1.64	2.57	1.40	3.27	0.47	1.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	869.65	1.04	1.24	0.21	0.83	0.41	0.00	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	926.65	1.77	1.11	1.99	1.99	0.88	1.55	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	888.18	1.04	0.84	1.25	0.42	0.84	0.42	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	953.67	0.40	1.35	0.40	0.94	0.13	0.54	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	714.73	0.34	0.68	0.34	0.68	0.85	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	871.24	2.51	0.77	0.58	1.35	0.77	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	836.82	0.34	0.52	0.86	1.03	0.69	0.34	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	740.30	1.51	0.41	0.82	1.10	0.96	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	828.56	1.81	1.15	0.99	0.82	0.99	0.99	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	775.97	0.68	0.85	0.85	1.36	0.17	1.02	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	1037.92	1.33	1.33	0.89	0.44	0.89	0.30	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	755.67	1.60	1.07	1.07	0.27	0.27	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	1280.35	0.83	1.24	0.55	1.66	0.28	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	1205.99	1.19	1.19	1.67	0.24	1.19	1.43	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	987.15	0.60	0.60	0.81	0.60	0.60	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	1171.25	1.32	1.70	1.04	1.70	0.66	1.22	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	2040.63	3.14	3.14	2.45	2.45	1.05	1.75	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	1092.20	1.51	1.21	0.91	1.21	0.60	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	974.56	0.61	0.61	1.10	0.61	0.86	1.47	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	1103.43	1.31	0.73	1.02	0.29	0.58	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	1255.80	1.22	3.04	1.83	0.61	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	835.78	1.21	0.90	1.21	0.30	0.00	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	1491.71	2.71	2.71	2.26	1.36	2.26	1.81	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	1221.53	2.10	2.10	2.70	1.20	1.50	2.10	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	1264.93	0.94	1.30	0.83	1.06	2.36	1.89	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	1141.50	4.70	1.07	4.70	4.91	3.84	0.64	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	972.98	1.80	0.60	1.20	3.00	1.80	0.60	0.60
Schwann Cells, donor1	11498-119F4	2239.36	1.13	4.89	2.63	3.01	1.13	0.94	0.94
Schwann Cells, donor2	11578-120F3	1241.88	3.40	0.00	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	1066.71	1.31	4.60	3.72	0.22	0.44	1.75	0.66
Sebocyte, donor1	11220-116B5	2013.60	1.64	1.10	1.10	0.00	0.55	0.55	1.10
Sebocyte, donor2	11301-117B5	1649.34	4.60	3.68	3.68	3.22	2.76	2.30	5.06
Sebocyte, donor3	11378-118B1	2247.66	6.80	3.71	4.33	4.53	5.36	1.86	1.03
Sertoli Cells, donor1	11255-116F4	1587.02	6.63	3.31	1.66	0.00	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	2349.87	8.47	8.47	8.47	5.65	8.47	8.47	11.30
Skeletal Muscle Cells, donor1	11281-116I3	3204.86	2.73	2.20	2.29	0.97	3.17	7.92	2.46
Skeletal Muscle Cells, donor2	11358-117H8	2991.13	2.89	8.67	5.06	3.61	10.12	2.17	2.17
Skeletal Muscle Cells, donor3	11430-118G8	2431.20	0.00	4.18	9.20	1.67	1.67	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	1498.67	3.61	2.20	3.77	3.61	2.83	1.10	1.10
Skeletal Muscle Cells, donor5	11455-119A6	1584.55	2.38	4.16	3.12	3.57	3.12	0.89	1.19
Skeletal Muscle Cells, donor6	11459-119B1	1503.94	1.85	2.92	3.85	1.69	2.31	0.62	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	2718.96	4.91	3.40	2.65	2.90	3.53	1.26	1.64
Skeletal Muscle Satellite Cells, donor2	11321-117D7	2119.07	7.71	3.57	4.00	2.57	2.57	1.85	2.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	1668.81	4.56	2.68	3.27	2.68	1.79	1.19	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	2414.41	1.18	1.01	1.60	0.51	1.18	2.27	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2164.05	2.90	6.51	3.62	3.62	2.17	0.72	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	1578.95	2.61	5.78	3.58	3.58	2.34	1.79	0.55
Skin - palm, donor1	10286-104F7	494.24	0.00	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	781.18	1.73	2.88	3.75	2.16	1.44	2.16	1.30
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	670.67	0.82	0.82	1.64	0.82	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	925.15	3.51	4.15	4.28	1.56	2.73	1.56	1.82
Small Airway Epithelial Cells, donor1	11256-116F5	1362.42	1.67	2.36	2.22	1.11	1.39	0.70	2.78
Small Airway Epithelial Cells, donor2	11334-117F2	908.93	2.11	1.55	1.55	1.27	1.97	0.56	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	769.87	1.69	0.63	0.85	0.42	0.21	0.00	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	898.58	3.00	2.40	1.80	2.40	1.65	0.52	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1875.57	1.85	2.47	2.47	3.39	2.16	5.55	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1268.84	0.44	1.78	0.89	0.44	0.67	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	2053.28	2.94	4.11	0.00	0.59	1.76	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	2424.94	1.33	1.77	1.33	1.77	1.33	1.55	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2432.77	1.97	0.39	0.39	0.39	1.97	0.79	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	2360.97	1.55	3.09	0.77	3.09	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	2665.01	3.00	10.01	4.00	0.00	5.00	8.01	4.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	2312.36	2.66	1.20	0.93	2.13	1.46	1.86	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	1677.04	1.77	3.32	5.76	0.44	1.77	2.44	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1609.34	1.54	1.54	2.05	2.94	3.46	0.77	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	1279.90	1.95	2.28	1.30	2.28	1.30	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	1128.14	2.07	2.07	1.48	0.30	1.77	1.48	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	1221.63	3.27	2.70	2.85	1.99	1.71	1.71	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2491.36	2.28	2.28	2.60	1.30	0.65	0.16	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	1888.70	2.13	3.35	2.13	2.44	2.44	0.30	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	3609.13	3.03	2.02	3.79	3.03	3.79	1.77	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	710.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1942.16	5.25	8.58	0.95	3.34	2.86	0.48	3.34
Smooth Muscle Cells - Colonic, donor1	11239-116D6	1245.27	1.92	2.21	1.62	0.29	1.03	0.59	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	1587.82	3.44	3.66	5.38	3.01	1.94	1.94	2.15
Smooth Muscle Cells - Colonic, donor3	11396-118D1	1498.70	3.88	3.99	2.41	2.62	2.62	1.15	1.68
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2670.37	2.47	0.77	1.24	1.39	0.93	1.24	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1739.69	6.47	9.70	3.23	5.39	3.23	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	1356.21	0.90	4.18	1.79	0.90	1.49	2.09	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2833.96	1.71	2.39	1.02	2.05	1.37	1.37	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	3341.96	2.12	2.75	3.61	1.02	1.41	1.26	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1700.13	2.31	2.72	3.12	0.60	2.11	6.74	2.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	787.79	0.91	3.19	2.96	0.68	0.00	2.28	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2529.97	0.60	6.64	3.02	3.62	1.21	3.62	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	1922.30	2.91	2.12	2.91	1.59	1.85	0.53	2.65
Smooth Muscle Cells - Prostate, donor1	11257-116F6	1619.88	1.07	1.60	1.73	0.93	1.33	2.00	1.73
Smooth Muscle Cells - Prostate, donor2	11335-117F3	1894.70	3.88	7.14	7.89	3.26	3.13	4.01	3.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	1576.77	2.54	3.55	0.76	1.27	3.04	2.03	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	2225.26	1.66	2.41	1.51	1.66	1.21	1.81	1.21
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	1997.70	3.75	7.50	3.00	0.00	1.50	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12097.72	1.29	6.46	5.17	5.17	3.88	7.75	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	2978.78	3.26	4.65	3.26	4.65	3.26	0.93	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	1463.65	1.51	5.55	4.04	2.02	2.52	3.03	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	1159.56	2.51	3.76	3.45	2.19	1.25	1.25	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2118.68	5.01	5.31	2.36	1.18	1.47	1.47	1.77
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1252.93	1.00	0.83	0.33	0.25	0.25	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	1811.64	3.74	3.27	4.67	1.87	2.34	2.34	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	2505.76	2.30	1.73	2.01	1.15	1.58	0.86	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	1803.81	4.59	3.57	4.59	2.55	1.78	1.53	1.78
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1603.55	2.26	3.57	3.01	2.26	2.44	1.88	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	1591.41	0.98	0.84	1.26	0.56	0.28	0.56	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	2521.10	0.59	1.68	1.42	0.67	0.50	0.75	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1942.82	4.29	3.33	2.86	4.29	3.33	2.38	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	2400.62	1.96	1.47	1.47	1.71	1.22	1.71	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	1696.44	0.66	3.09	0.66	1.33	1.99	1.99	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	1184.94	2.63	2.63	2.93	2.93	2.63	0.59	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	1637.29	2.53	1.94	1.36	2.72	3.89	1.75	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	767.44	2.12	2.38	2.64	1.06	0.53	0.79	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1591.56	2.98	3.35	3.72	1.86	3.35	2.98	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	1537.24	1.44	2.16	6.11	2.52	1.44	0.72	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	672.84	0.57	2.27	1.70	1.42	1.14	0.85	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	945.28	1.18	0.79	3.15	1.97	0.39	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	1372.10	3.30	4.83	4.57	2.79	6.86	2.29	3.30
Smooth muscle cells - airway, control, donor2	11967-126D5	1479.08	2.00	3.59	2.40	3.99	5.59	4.79	2.80
Smooth muscle cells - airway, control, donor3	11968-126D6	1427.49	6.69	5.85	3.76	4.60	3.76	5.85	2.93
Smooth muscle cells - airway, control, donor4	11969-126D7	1469.05	3.67	0.46	0.92	2.29	1.83	1.83	2.75
Synoviocyte, donor1	11291-117A4	1856.41	4.04	1.85	2.02	1.35	1.01	5.22	0.84
Synoviocyte, donor2	11368-117I9	1660.65	2.85	4.69	4.53	0.50	1.34	4.02	2.01
Synoviocyte, donor3	11440-118H9	1762.03	2.23	4.69	4.69	0.89	4.24	3.80	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	2705.71	2.14	2.50	1.07	2.50	1.07	0.71	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	2980.99	5.95	5.95	1.98	0.00	3.96	1.98	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	2299.96	3.70	3.24	1.85	0.93	0.93	0.69	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	2321.21	2.08	1.58	1.51	2.44	1.00	0.50	0.93
Tracheal Epithelial Cells, donor2	11369-118A1	1995.44	2.32	2.71	2.32	2.32	1.55	0.77	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	1788.42	1.72	6.30	6.30	3.44	2.29	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	1449.35	1.60	1.48	1.35	1.11	1.11	1.35	3.08
Urethra, donor2	10319-105A4	672.61	3.60	0.00	1.80	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	1734.50	1.33	1.86	1.06	2.92	0.80	0.53	1.06
Urothelial Cells, donor2	11600-120H7	1548.18	3.61	3.20	1.20	1.20	1.20	0.80	1.20
Urothelial Cells, donor3	11681-122H7	1753.88	4.58	3.44	2.75	0.92	1.38	1.60	1.38
Urothelial cells, donor0	11216-116B1	1910.66	0.89	1.56	0.89	0.22	1.78	0.67	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	1827.61	0.00	0.89	1.78	0.00	1.78	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1912.82	0.00	0.00	2.86	0.00	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	1059.64	0.00	3.42	2.74	1.37	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	1418.33	1.03	1.03	1.38	0.00	1.03	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	1626.30	1.16	1.74	0.00	1.74	0.00	2.32	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	1572.27	0.00	3.12	2.08	0.00	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	1622.66	1.84	3.67	1.84	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	1245.19	3.65	2.74	0.91	1.83	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	1401.26	4.44	1.97	2.59	2.22	2.47	1.11	2.22
Wilms' tumor cell line:HFWT	10597-108E3	888.84	0.88	6.16	1.76	4.40	0.88	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1125.65	2.23	0.84	0.56	1.68	2.23	0.28	0.56
achilles tendon, donor2	10292-104G4	508.37	6.20	0.00	2.07	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1573.08	4.33	2.29	2.29	1.02	0.51	0.76	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	2499.59	2.79	2.09	1.39	1.63	0.93	0.23	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1507.47	1.90	1.66	0.95	0.83	0.95	0.71	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	1372.00	3.27	2.18	1.36	0.54	0.54	0.54	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1121.52	3.65	4.50	2.53	4.22	2.53	0.84	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	1153.42	1.90	1.69	0.63	1.90	0.85	0.00	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	2924.64	5.72	3.81	4.63	6.53	3.54	1.36	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	2517.37	4.41	5.73	7.93	4.85	2.64	2.20	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	1652.22	4.90	3.68	4.49	4.49	2.04	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	2916.90	5.44	6.21	2.72	5.05	5.05	1.16	3.49
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2267.62	4.60	4.60	5.89	1.84	2.21	2.21	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	2195.99	0.00	3.90	11.70	7.80	11.70	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	2014.29	5.11	2.79	3.25	3.95	3.72	2.32	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	3438.21	8.03	7.77	5.44	6.99	4.14	2.33	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1702.03	3.80	5.26	2.92	2.34	2.63	0.58	2.92
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	738.50	0.93	0.00	0.93	1.39	0.93	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	984.95	2.06	2.06	2.06	2.47	2.06	2.06	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1159.35	5.22	1.23	2.15	2.76	1.23	0.31	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1578.82	3.41	1.71	2.13	1.71	0.00	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1542.25	1.52	0.30	0.91	0.91	0.00	0.61	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1749.21	2.41	1.44	1.20	0.96	0.48	0.24	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1123.05	2.00	1.34	2.45	2.67	0.67	0.67	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1047.00	2.00	3.00	0.67	1.33	1.00	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	250.86	0.00	1.86	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	760.48	1.88	0.38	1.51	0.38	0.00	1.51	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	765.85	3.49	1.74	0.00	1.31	0.44	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	339.28	1.87	5.62	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	1366.13	2.12	0.71	0.94	2.12	1.88	0.94	0.24
adipose tissue, adult, pool1	10010-101C1	1494.26	0.93	1.55	1.55	0.62	2.64	1.71	2.95
adipose, donor1	10184-103D4	1233.22	7.62	4.10	2.93	6.45	13.49	2.93	6.45
adipose, donor2	10185-103D5	808.60	3.24	3.65	2.43	2.43	6.08	4.46	5.27
adipose, donor3	10186-103D6	829.66	2.45	4.08	1.36	2.72	6.81	1.36	1.91
adipose, donor4	10187-103D7	1033.17	7.80	2.60	5.20	2.60	8.67	4.33	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1631.39	3.31	2.37	1.58	2.68	2.37	0.79	0.95
adrenal gland, adult, pool1	10081-102A9	749.36	3.64	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	1137.42	1.20	0.67	1.07	0.67	0.67	0.13	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	1657.87	5.36	4.64	1.79	2.86	3.22	1.79	2.14
amniotic membrane cells, donor1	12235-129G3	788.29	0.93	1.62	0.70	0.93	0.70	0.23	0.93
amniotic membrane cells, donor2	12236-129G4	768.17	1.35	0.00	1.35	0.68	2.37	1.01	1.35
amniotic membrane cells, donor3	12237-129G5	1172.81	0.88	1.77	2.36	2.06	0.88	0.29	0.00
amygdala - adult, donor10196	10167-103B5	596.46	1.19	0.00	0.00	0.00	2.37	0.00	1.19
amygdala, adult, donor10252	10151-102I7	728.54	1.22	0.81	0.41	0.20	0.41	0.81	0.81
amygdala, newborn, donor10223	10360-105E9	816.93	0.65	0.97	0.32	0.00	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	1445.96	2.04	1.40	0.89	0.76	1.27	0.89	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	3501.07	7.94	5.29	4.19	3.97	5.07	2.65	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1993.53	2.34	3.01	2.00	2.34	2.67	0.33	0.67
aorta, adult, pool1	10052-101G7	1148.55	6.28	2.55	1.96	2.94	2.16	0.98	0.78
appendix, adult	10189-103D9	1360.74	1.94	2.72	2.72	1.55	2.72	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1886.14	2.41	2.75	1.03	2.41	2.41	1.38	2.75
artery, adult	10190-103E1	1976.89	10.87	12.23	10.87	6.79	6.79	6.79	2.72
astrocytoma cell line:TM-31	10425-106D2	1075.35	1.88	1.45	1.45	0.87	0.87	0.29	0.58
b cell line:RPMI1788	10427-106D4	1744.71	1.78	1.64	1.19	1.49	0.45	0.15	1.64
basal cell carcinoma cell line:TE 354.T	10702-109G9	863.42	3.05	1.94	1.66	0.83	2.22	0.28	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	1253.59	0.89	1.49	0.60	0.79	0.30	0.20	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	611.43	1.00	1.34	0.33	0.17	0.33	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2922.02	3.36	6.15	4.47	6.15	5.03	1.12	1.68
bladder, adult, pool1	10011-101C2	1625.92	3.26	2.93	1.74	1.30	1.20	2.17	0.76
blood, adult, pool1	10053-101G8	876.99	0.00	4.43	6.64	6.64	0.00	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	364.80	0.00	2.57	0.00	0.00	1.71	0.00	0.00
bone marrow, adult	10192-103E3	1110.76	0.67	3.37	2.02	0.00	2.02	3.37	0.00
brain, adult, donor1	10084-102B3	1009.69	4.10	2.05	1.03	1.03	3.08	1.03	2.05
brain, adult, pool1	10012-101C3	926.17	0.89	1.11	0.67	0.56	0.56	0.22	0.67
brain, fetal, pool1	10085-102B4	2631.33	2.67	2.67	5.34	2.67	0.00	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	1667.35	5.95	9.58	4.63	2.31	1.98	0.66	3.96
breast carcinoma cell line:MDA-MB-453	10419-106C5	1106.05	1.12	0.75	0.50	0.25	0.50	0.25	0.87
breast, adult, donor1	10080-102A8	775.94	4.42	1.89	0.63	0.00	1.89	1.89	5.05
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1232.52	2.41	1.40	1.52	1.65	1.02	0.51	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	925.50	1.55	2.47	1.86	1.55	0.62	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1294.52	4.60	3.22	3.22	1.84	1.38	1.84	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	487.80	1.21	0.48	0.00	0.48	0.73	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	1462.69	6.58	4.23	1.41	2.35	3.29	1.88	2.35
carcinoid cell line:NCI-H727	10735-110B6	1127.38	2.41	2.30	1.42	1.09	0.88	0.66	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	2364.99	7.61	3.80	4.44	4.12	4.44	0.63	4.12
carcinosarcoma cell line:JHUCS-1	10642-109A3	2793.80	5.86	4.26	5.32	10.65	3.46	2.13	0.53
caudate nucleus - adult, donor10196	10177-103C6	596.39	0.00	0.00	0.00	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	716.32	1.17	0.67	1.17	0.84	0.50	0.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	1103.42	1.53	0.76	1.53	0.76	0.76	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	1312.21	1.46	0.73	1.46	1.83	0.37	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	871.07	5.83	0.00	0.00	0.00	0.00	0.00	8.74
cerebellum, adult, donor10252	10166-103B4	871.12	2.35	1.28	2.35	1.07	0.64	0.85	0.21
cerebellum, adult, pool1	10083-102B2	1091.75	3.45	2.07	1.38	2.76	1.72	1.38	0.69
cerebellum, newborn, donor10223	10357-105E6	1551.81	4.98	2.49	0.00	1.66	2.49	0.00	0.00
cerebral meninges, adult	10188-103D8	857.02	2.02	1.76	2.27	1.01	0.50	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	529.89	5.12	5.85	6.58	3.65	4.39	2.19	0.73
cervical cancer cell line:D98-AH2	10552-107I3	3425.33	3.16	2.73	2.30	1.44	1.44	1.01	1.29
cervical cancer cell line:ME-180	10553-107I4	1999.20	1.16	0.83	0.83	1.33	1.49	1.16	0.33
cervix, adult, pool1	10013-101C4	1795.44	1.26	1.78	1.99	1.78	2.10	1.26	1.89
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	966.17	1.67	0.70	0.84	0.42	0.56	0.28	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	346.16	0.00	2.61	0.00	3.92	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	1739.37	2.73	2.24	1.37	1.12	4.10	3.23	1.86
choriocarcinoma cell line:SCH	10785-110H2	766.87	1.36	0.74	0.37	0.86	0.49	0.86	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	684.26	0.47	0.71	0.24	1.19	0.71	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	804.61	1.99	3.13	3.13	2.28	1.42	0.57	0.57
chorionic membrane cells, donor2	12239-129G7	854.31	1.19	0.99	0.89	1.49	1.59	0.70	0.89
chorionic membrane cells, donor3	12240-129G8	1292.39	6.59	7.14	8.24	2.20	3.30	1.65	2.75
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1401.60	2.02	3.03	7.07	11.11	4.04	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	1540.44	2.11	0.96	1.15	2.88	3.46	0.58	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	822.78	1.69	1.90	1.90	0.84	0.63	0.00	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1477.38	0.51	2.82	1.03	1.03	1.54	0.51	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1709.84	2.18	1.69	1.21	1.69	0.73	0.73	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1527.48	3.46	3.26	1.02	0.41	0.81	0.61	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	1582.40	3.24	3.24	1.18	1.77	1.47	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	2779.83	3.13	1.82	1.04	2.61	0.52	0.52	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	658.54	2.29	3.89	2.29	1.60	1.14	2.06	0.91
clear cell carcinoma cell line:TEN	10636-108I6	1857.73	2.95	2.08	2.60	3.47	1.21	0.69	1.39
colon carcinoma cell line:CACO-2	10513-107D9	1178.61	1.46	1.46	0.55	0.55	0.92	0.00	0.73
colon carcinoma cell line:COLO-320	10420-106C6	2422.26	2.28	2.28	1.14	2.28	0.76	0.38	0.76
colon, adult, donor1	10082-102B1	1411.38	3.57	3.57	1.19	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	1627.19	1.41	0.71	0.71	2.12	3.88	2.59	1.41
colon, fetal, donor1	10070-101I7	1197.66	4.33	0.00	0.62	3.09	1.85	0.62	1.85
common myeloid progenitor CMP, donor1	12130-128D6	2264.26	0.00	4.58	9.17	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	2103.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1443.92	0.85	1.70	0.42	0.85	1.70	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1317.78	2.41	1.51	1.66	0.60	1.81	1.06	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	1586.24	2.26	1.41	0.85	1.27	0.99	0.14	0.71
corpus callosum, adult, pool1	10042-101F6	1232.11	0.77	0.77	1.33	0.22	1.00	0.55	0.22
cruciate ligament, donor2	10295-104G7	655.67	3.24	0.81	3.24	0.00	2.43	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	995.18	7.22	6.42	1.61	5.62	2.41	2.41	1.61
diencephalon, adult	10193-103E4	604.05	0.96	2.64	0.72	2.16	0.48	0.96	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	4003.27	13.09	9.87	10.56	8.27	6.43	3.21	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	792.91	0.77	0.51	0.77	1.28	0.51	0.26	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	1883.65	4.33	1.93	1.93	2.89	1.44	0.96	1.69
ductus deferens, adult	10196-103E7	1358.47	2.49	3.99	3.49	1.99	0.50	1.00	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	1533.85	10.08	7.20	1.44	0.00	1.44	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	1774.39	5.15	11.03	4.41	3.68	3.68	2.94	3.68
dura mater, adult, donor1	10041-101F5	1839.30	1.24	1.07	1.49	0.66	0.58	0.33	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	5477.43	6.66	5.77	4.22	7.55	11.77	7.55	7.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	3221.67	6.02	4.30	1.58	3.44	3.58	1.43	2.01
embryonic pancreas cell line:1B2C6	10604-108F1	398.95	0.00	1.23	0.62	0.00	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	873.32	2.42	1.51	0.91	0.91	0.00	0.00	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	492.76	1.23	0.31	0.00	0.00	0.93	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	416.37	0.00	1.31	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	279.22	0.00	0.34	0.00	0.34	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	1589.43	1.99	2.54	1.63	1.27	0.54	1.45	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1231.99	5.31	4.82	3.38	2.57	2.25	1.45	1.77
epidermoid carcinoma cell line:A431	10426-106D3	578.25	1.33	1.22	0.44	0.33	0.22	0.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	883.73	0.88	0.33	0.77	0.11	0.33	0.22	0.44
epididymis, adult	10197-103E8	1237.03	2.72	5.65	3.77	1.26	2.93	1.47	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	962.80	1.60	0.71	1.06	0.18	0.89	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1329.55	1.18	1.97	1.57	0.79	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1606.41	4.19	5.24	2.88	2.36	1.83	1.18	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	1762.01	3.05	2.95	3.94	1.38	1.18	0.39	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1541.75	5.49	4.26	2.24	2.24	1.68	0.78	1.12
esophagus, adult, pool1	10015-101C6	1644.48	2.55	1.81	2.65	1.70	1.91	2.65	3.19
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2780.49	3.76	2.50	1.88	1.25	2.00	0.88	1.63
eye - muscle inferior rectus, donor1	10272-104E2	519.13	26.56	4.83	4.83	4.83	7.24	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	643.89	2.10	2.10	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	416.70	2.98	1.49	4.46	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	398.98	3.44	2.29	2.29	0.00	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	447.42	2.91	2.91	0.00	0.00	4.37	0.00	4.37
eye, fetal, donor1	10054-101G9	1526.17	3.56	4.07	3.56	1.27	1.27	1.53	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	1571.52	3.08	1.67	1.41	1.92	1.80	0.77	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	1193.74	2.61	2.61	1.90	2.14	1.90	1.19	1.42
frontal lobe, adult, pool1	10040-101F4	1121.48	1.41	1.22	0.56	0.84	0.28	0.38	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	460.28	0.30	0.60	0.90	0.60	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	683.94	0.46	0.73	0.46	0.46	0.18	0.18	0.18
gall bladder, adult	10198-103E9	1387.27	1.93	2.90	1.69	2.90	4.59	1.93	0.97
gamma delta positive T cells, donor1	11937-126A2	1290.06	2.68	1.07	2.15	1.07	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	997.60	1.12	1.87	1.49	0.37	0.75	0.37	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	877.39	1.06	1.90	3.38	1.90	2.32	1.06	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	3311.86	8.32	7.54	5.22	3.29	4.84	2.51	4.06
gastric cancer cell line:AZ521	10549-107H9	2513.43	1.80	1.97	1.80	1.64	1.15	1.31	1.48
gastric cancer cell line:GSS	10560-108A2	1782.86	0.92	1.83	2.75	1.83	2.75	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	1768.26	4.11	2.74	4.57	4.34	1.83	2.74	1.83
giant cell carcinoma cell line:LU65	10487-107B1	2394.63	3.33	3.33	3.33	1.72	2.18	1.61	2.64
giant cell carcinoma cell line:Lu99B	10433-106E1	1361.24	0.70	0.70	0.98	0.84	0.70	0.56	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	236.95	0.50	1.50	0.75	0.75	0.25	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	654.95	0.84	0.95	0.63	0.53	0.42	0.11	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	648.69	1.12	0.84	0.14	0.70	0.28	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	1043.25	1.10	0.88	0.66	0.66	0.44	0.22	0.77
glioma cell line:GI-1	10413-106B8	1493.38	2.64	0.88	1.76	0.88	0.88	0.59	1.17
globus pallidus - adult, donor10196	10175-103C4	463.59	0.00	0.00	0.73	0.00	0.00	0.00	1.46
globus pallidus, adult, donor10252	10161-103A8	764.75	2.69	1.22	0.98	0.24	0.00	0.73	0.73
globus pallidus, adult, donor10258	10367-105F7	502.50	4.11	9.58	4.11	0.00	4.11	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	926.21	0.53	1.60	1.60	2.13	2.13	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	1874.51	0.00	7.34	7.34	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	2032.68	10.93	10.93	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	1923.38	0.00	5.23	0.00	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	809.27	3.52	2.24	1.92	1.60	2.56	0.00	1.28
hIPS +CCl2, biol_rep1	14383-156B9	1602.31	0.92	1.38	2.75	0.46	2.75	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	1613.22	0.91	4.12	2.74	1.37	2.74	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	1661.11	1.93	1.29	1.93	0.64	1.29	3.22	1.29
hIPS, biol_rep1	14380-156B6	679.84	4.31	1.44	1.44	1.44	5.75	2.87	0.00
hIPS, biol_rep2	14381-156B7	1150.89	2.74	1.37	2.06	1.37	2.74	2.74	2.06
hIPS, biol_rep3	14382-156B8	835.33	1.10	1.10	2.21	3.31	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	1660.56	4.60	2.87	2.01	2.30	1.72	1.72	2.30
heart - mitral valve, adult	10205-103F7	941.45	4.19	3.29	1.49	1.20	2.09	0.60	2.09
heart - pulmonic valve, adult	10206-103F8	1154.94	4.18	1.31	1.57	0.52	0.00	0.78	1.31
heart - tricuspid valve, adult	10207-103F9	774.36	2.50	0.00	1.67	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	1164.75	4.08	2.65	2.24	0.82	1.43	1.63	1.63
heart, adult, diseased, donor1	10051-101G6	1604.54	3.41	4.26	4.26	2.13	3.41	2.13	2.55
heart, adult, pool1	10016-101C7	1436.67	3.91	4.37	2.07	1.38	1.38	0.69	0.23
heart, fetal, pool1	10046-101G1	2495.64	1.33	1.13	1.44	0.82	0.72	0.51	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	1154.19	3.39	1.54	0.93	2.78	1.54	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	717.07	4.76	1.19	3.57	2.38	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	1254.02	2.76	2.10	2.43	1.33	1.33	0.44	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	1264.72	3.16	2.43	2.18	1.58	2.06	0.49	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	1358.36	2.73	2.63	2.12	1.11	0.91	0.30	0.10
hepatoma cell line:Li-7	10484-107A7	453.54	0.67	0.44	0.67	0.22	0.44	0.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	2016.94	2.51	1.41	1.71	1.51	1.11	0.90	1.11
hippocampus - adult, donor10196	10169-103B7	500.61	2.84	0.00	0.95	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	814.56	1.02	1.84	2.04	0.00	0.00	0.61	0.61
hippocampus, adult, donor10258	10374-105G5	669.25	0.50	0.50	0.50	1.49	0.50	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	692.97	1.06	2.11	2.11	1.06	2.11	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	2755.09	9.16	4.88	6.10	7.32	12.21	3.66	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	2027.36	5.69	6.09	4.91	4.32	7.27	3.14	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	2410.23	6.35	4.82	4.32	6.60	6.60	1.02	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1851.73	2.82	5.07	2.82	10.71	6.77	5.07	11.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1770.30	12.65	7.75	10.07	17.04	17.30	11.36	18.85
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	2373.70	6.07	5.31	4.56	12.53	12.91	4.18	10.25
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	1451.59	2.92	4.96	2.92	10.22	9.34	0.58	5.55
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1445.96	4.74	3.66	4.31	9.05	10.13	2.80	6.89
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1295.85	0.42	2.09	1.67	2.92	6.26	0.83	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	1010.63	0.95	2.37	2.37	2.60	3.32	1.18	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1321.74	4.50	4.82	2.09	5.14	7.23	1.29	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	1066.51	2.69	0.00	0.00	0.00	0.00	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	2213.00	6.73	5.79	5.01	3.76	7.98	2.35	2.66
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	2082.60	7.86	12.77	10.32	11.79	11.30	5.40	7.86
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3002.27	2.62	5.24	8.73	12.22	15.71	4.36	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1679.44	4.77	3.25	4.39	9.16	8.40	4.20	6.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	1575.53	1.74	6.11	2.62	6.54	6.98	4.80	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1499.78	4.00	5.00	4.00	13.99	9.50	4.00	8.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1347.94	3.96	4.90	3.20	8.85	10.17	4.71	7.16
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1355.51	4.55	4.09	1.36	7.73	5.00	3.18	6.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1273.30	4.07	2.82	3.13	4.70	5.33	3.13	6.26
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	976.22	3.76	5.06	4.25	2.61	4.57	2.94	3.76
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	904.60	2.61	4.35	4.35	3.19	4.64	3.77	4.35
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	982.56	2.99	2.99	2.99	3.59	4.48	1.49	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1973.26	6.47	7.94	5.36	5.54	9.05	3.51	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1804.99	4.28	3.71	2.28	4.85	7.13	3.42	4.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2602.58	6.12	4.08	7.76	6.53	8.98	3.67	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1267.14	5.99	5.99	5.99	7.39	10.56	2.46	8.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	1273.61	3.80	4.12	3.48	6.33	6.97	4.43	6.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1587.24	5.45	2.72	1.82	6.36	6.36	1.51	8.47
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	1065.27	3.10	3.62	2.07	3.62	3.10	3.10	7.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	989.61	2.66	5.31	4.65	3.32	4.65	2.66	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1027.93	2.57	3.08	3.59	1.54	1.54	0.77	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	968.91	4.09	5.11	3.32	3.83	4.09	2.81	4.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	1084.34	1.51	3.03	3.03	1.51	3.03	2.27	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	951.38	2.35	3.70	2.69	3.02	1.68	1.34	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	2009.81	3.38	6.04	4.59	5.80	8.69	3.38	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	2311.19	4.46	5.35	8.47	8.47	12.48	3.12	3.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	2170.26	5.85	5.85	4.39	8.29	7.80	2.44	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1457.19	3.36	3.67	3.67	7.95	6.42	6.72	5.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1851.10	22.77	9.76	3.25	26.03	32.53	6.51	32.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2260.67	5.96	5.30	3.97	11.25	9.27	5.30	10.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1279.04	2.74	4.38	3.28	8.21	4.93	1.09	6.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1332.46	1.09	5.43	2.90	4.34	4.34	2.17	5.43
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1306.40	2.14	2.14	4.27	7.47	4.63	3.20	5.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	1088.37	2.39	4.77	3.58	4.77	8.35	5.97	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	1358.59	1.08	1.76	1.35	3.25	4.33	2.71	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	912.71	1.62	2.96	2.42	0.81	1.62	0.54	2.42
immature langerhans cells, donor1	11904-125F5	717.72	0.97	1.45	0.97	1.45	0.97	0.00	0.48
immature langerhans cells, donor2	11905-125F6	849.96	1.58	0.00	1.58	0.79	1.58	1.58	0.00
insula, adult, pool1	10039-101F3	1304.71	0.85	0.66	0.28	0.66	0.57	0.00	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	966.66	1.95	0.98	0.65	0.33	1.30	0.33	0.65
kidney, adult, pool1	10017-101C8	1041.22	1.80	1.50	1.20	1.50	0.50	1.30	0.50
kidney, fetal, pool1	10045-101F9	2199.60	1.63	1.34	1.41	0.99	0.85	1.34	0.78
large cell lung carcinoma cell line:IA-LM	10509-107D5	2020.25	0.71	1.42	1.42	1.28	0.43	0.14	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2546.55	5.94	5.11	5.94	5.67	4.29	2.21	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	642.62	1.28	0.00	0.37	0.18	0.55	0.00	0.18
left atrium, adult, donor1	10079-102A7	1006.34	3.81	2.18	2.18	3.81	0.54	2.72	4.90
left ventricle, adult, donor1	10078-102A6	1065.92	2.53	3.03	1.01	3.03	0.51	2.53	4.55
leiomyoblastoma cell line:G-402	10721-110A1	1370.51	2.74	3.01	1.09	2.19	2.19	0.55	0.55
leiomyoma cell line:10964C	10569-108B2	1283.60	5.39	5.03	5.03	4.31	4.31	3.23	1.80
leiomyoma cell line:15242A	10570-108B3	948.92	2.72	2.72	4.89	1.63	0.00	1.63	1.09
leiomyoma cell line:15425	10571-108B4	1075.43	3.40	5.58	3.40	3.89	1.94	2.91	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	819.07	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	576.10	0.00	0.00	1.05	1.05	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1760.60	4.13	1.77	1.89	1.18	1.42	0.94	0.71
liposarcoma cell line:KMLS-1	10782-110G8	1452.91	4.69	3.12	2.97	2.81	2.03	0.94	1.87
liposarcoma cell line:SW 872	10726-110A6	748.34	1.34	1.34	0.73	0.85	0.85	0.24	0.24
liver, adult, pool1	10018-101C9	1951.22	2.59	3.08	2.27	1.78	2.43	1.62	6.81
liver, fetal, pool1	10086-102B5	663.20	0.00	1.88	0.00	0.94	2.82	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	535.18	0.73	1.31	0.29	1.02	0.44	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	656.63	1.66	2.40	0.92	0.37	0.55	0.18	0.55
locus coeruleus, adult, donor10258	10375-105G6	643.27	2.82	4.23	3.67	1.69	1.13	1.13	0.56
locus coeruleus, newborn, donor10223	10362-105F2	1029.67	2.10	1.26	0.84	1.26	3.36	0.42	0.84
lung adenocarcinoma cell line:A549	10499-107C4	882.96	0.83	0.55	0.28	0.55	0.28	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	317.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	625.73	3.95	3.56	1.05	1.32	2.37	0.66	0.40
lung, adult, pool1	10019-101D1	1283.81	2.13	2.72	0.83	1.06	1.65	1.77	2.60
lung, fetal, donor1	10068-101I5	1981.30	1.43	1.43	0.57	1.14	1.14	0.57	1.71
lung, right lower lobe, adult, donor1	10075-102A3	715.28	4.58	1.83	2.29	2.75	1.83	2.29	3.67
lymph node, adult, donor1	10077-102A5	1336.78	0.95	2.84	3.31	2.84	1.89	2.84	5.21
lymphangiectasia cell line:DS-1	10727-110A7	2789.69	3.73	2.63	2.19	1.53	3.73	2.41	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1397.73	3.62	1.81	1.81	2.41	2.11	1.06	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	403.51	0.00	0.85	0.85	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	1557.52	3.11	1.33	0.89	3.11	0.89	1.33	0.00
mature adipocyte, donor2	12232-129F9	1418.87	1.25	0.42	1.66	0.62	0.62	0.21	0.21
mature adipocyte, donor3	12233-129G1	1791.01	1.66	0.95	2.13	2.13	2.13	0.71	0.95
mature adipocyte, donor4	12234-129G2	1946.49	2.63	1.84	0.53	1.58	0.79	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1110.76	0.95	0.48	0.24	0.48	1.19	0.24	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	667.79	0.00	1.13	2.26	0.00	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	817.83	1.47	0.92	2.39	0.18	0.37	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	555.64	0.95	0.95	0.95	1.27	0.95	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	1101.62	2.56	1.71	0.00	0.43	1.28	0.85	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	812.37	3.21	1.69	1.86	1.18	1.18	1.01	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	734.30	2.12	1.27	1.49	0.21	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	375.62	1.93	1.93	0.00	1.93	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	373.19	14.35	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	1218.22	0.72	0.72	1.08	1.79	0.72	0.72	0.72
medulla oblongata - adult, donor10196	10174-103C3	523.08	2.60	1.30	0.65	0.00	0.65	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	720.15	1.08	0.31	0.93	0.46	0.46	0.15	0.31
medulla oblongata, adult, pool1	10038-101F2	1046.54	0.73	0.98	0.65	0.82	0.41	0.57	0.24
medulla oblongata, newborn, donor10223	10361-105F1	833.23	1.04	0.69	1.04	0.69	0.69	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	6191.34	8.86	7.75	5.54	7.53	5.76	3.10	1.99
medulloblastoma cell line:ONS-76	10759-110E3	436.64	0.86	0.24	0.12	0.37	0.49	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	1254.62	1.87	2.01	1.01	1.29	1.29	1.72	1.01
melanoma cell line:G-361	10465-106H6	1510.96	3.26	2.44	1.36	2.99	3.26	4.61	2.17
meningioma cell line:HKBMM	10691-109F7	985.75	4.16	5.07	2.71	3.80	1.99	1.27	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	1457.43	14.10	11.46	2.64	12.34	5.29	1.76	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	977.79	3.11	1.30	2.85	2.07	1.04	0.52	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	1657.86	1.69	2.61	3.68	2.15	0.92	0.92	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	1771.09	1.82	2.54	2.36	1.27	1.09	2.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	1429.48	1.24	2.07	1.66	1.24	2.90	0.83	2.90
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	1299.68	1.40	2.11	1.55	1.26	0.98	0.28	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	1513.20	3.47	1.73	4.43	1.54	1.93	1.35	1.73
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	844.00	0.69	1.39	1.39	0.69	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	1758.05	1.89	2.75	3.26	3.09	2.40	1.20	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	1592.85	1.84	3.80	2.99	2.07	1.38	1.27	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	1167.60	1.19	1.19	1.86	1.72	1.19	0.66	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	889.51	1.49	1.35	1.76	1.22	0.81	0.68	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	808.48	1.14	0.85	1.14	1.14	0.14	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1634.92	2.31	2.96	1.98	0.99	2.96	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	1120.81	0.55	1.80	2.21	0.97	0.55	1.25	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	914.95	1.40	2.79	4.89	0.70	1.75	0.35	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1071.25	2.86	3.06	2.45	0.61	1.63	0.41	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	1126.89	1.08	1.80	1.80	3.24	1.80	2.16	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	1230.85	1.66	1.66	1.66	1.45	0.83	0.83	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	612.16	1.37	1.60	1.37	0.91	1.37	0.46	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	871.00	2.52	1.68	3.36	1.26	0.42	0.42	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	1094.18	2.54	1.79	1.20	1.20	1.34	0.15	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	1249.67	1.66	1.84	1.58	1.58	0.44	0.70	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	1464.17	3.68	3.68	3.31	2.58	2.21	2.58	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	1025.59	1.72	1.43	0.57	2.00	0.57	0.57	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	885.39	5.05	2.11	2.95	3.79	3.79	1.26	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	1352.66	3.65	1.37	1.83	2.74	0.46	1.83	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	1288.90	2.05	2.56	2.81	2.05	1.79	1.02	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	1340.19	3.14	2.09	2.09	2.09	3.40	0.79	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	1249.60	3.39	3.08	1.85	1.54	1.85	1.54	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	1239.61	4.47	3.06	2.59	2.82	3.77	1.65	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	1330.47	3.72	3.72	2.37	4.40	3.38	0.68	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	1352.22	2.75	3.54	3.14	1.57	0.79	1.57	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	1335.48	3.24	4.17	2.32	4.17	1.85	1.39	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	1352.50	0.00	0.00	0.00	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	1659.26	3.17	2.31	3.75	3.75	3.17	1.44	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	1336.59	2.23	2.90	2.45	1.78	0.67	2.68	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	1360.63	3.12	5.29	2.16	1.68	1.92	1.68	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	760.46	3.67	2.20	0.00	2.93	2.20	1.47	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	1349.34	2.01	2.69	2.01	3.36	2.35	0.67	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	1299.78	2.87	2.05	2.05	2.87	3.28	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	1363.42	3.44	1.29	0.86	1.29	2.15	1.72	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	1681.66	8.20	2.73	5.47	5.47	0.00	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	1518.51	10.33	15.49	5.16	10.33	0.00	10.33	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	1521.95	3.57	4.22	4.55	4.87	3.25	2.27	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	1529.19	7.27	2.91	10.18	8.73	4.36	2.91	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	1588.04	4.80	4.80	4.80	5.33	3.20	1.07	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	1440.91	3.27	3.27	4.09	1.64	0.82	0.82	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	1429.71	3.50	5.05	5.05	6.61	5.44	1.94	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	1448.12	8.39	6.30	10.49	6.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	1577.63	4.97	2.98	8.94	5.96	4.97	0.99	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	1639.92	0.00	4.77	14.30	4.77	14.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	1312.23	4.74	2.96	6.52	4.15	2.96	3.56	4.15
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	1715.59	8.53	10.97	3.66	6.09	6.09	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	1514.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	1641.73	1.90	6.33	6.33	6.97	5.07	2.53	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	1783.15	3.79	4.83	4.48	3.79	2.41	1.72	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2054.64	12.90	10.75	2.15	2.15	10.75	2.15	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	1860.18	3.99	11.98	7.98	3.99	0.00	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	2317.73	17.22	13.78	10.33	3.44	13.78	3.44	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2450.12	4.89	5.30	6.93	4.89	4.48	4.48	3.26
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	2606.56	9.53	13.51	7.94	2.38	7.15	3.18	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2928.18	12.38	15.33	8.84	5.90	5.31	5.31	4.72
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2777.60	9.35	4.68	9.97	5.92	5.61	5.30	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2955.38	14.70	17.38	12.03	6.68	6.68	6.68	9.36
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2529.74	11.83	11.83	11.83	9.46	7.10	3.55	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2596.25	5.14	12.84	15.41	10.27	15.41	5.14	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	2792.14	10.33	7.57	5.51	4.82	5.51	0.69	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	2416.64	6.43	5.94	7.42	4.95	2.97	3.96	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	2191.42	8.97	7.85	4.49	5.61	4.49	4.49	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	2244.67	7.63	7.63	10.18	5.72	5.09	7.63	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1761.84	3.22	5.24	5.64	2.42	5.24	4.03	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2163.14	6.54	6.54	6.54	2.18	2.18	6.54	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1996.89	7.60	10.14	8.87	7.60	10.14	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	1617.96	1.82	4.25	3.03	3.03	3.64	3.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	1952.20	9.04	9.04	22.59	9.04	4.52	9.04	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	1640.77	4.12	6.59	3.29	3.29	2.47	3.29	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1282.03	2.18	2.18	1.19	1.39	1.59	0.40	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1598.13	2.27	4.87	1.95	3.57	4.54	1.95	2.27
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	1759.17	9.17	9.17	7.13	8.15	2.04	3.06	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	605.82	3.09	0.00	0.77	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	714.39	0.71	0.94	0.00	0.47	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	936.89	3.24	0.70	1.16	1.16	0.23	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	1444.48	0.00	0.00	0.00	4.27	0.00	0.00	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	1529.64	1.75	1.64	1.85	1.44	1.54	0.82	0.92
mesothelioma cell line:Mero-25	10850-111F4	784.58	1.13	2.50	2.04	0.45	1.59	0.91	0.68
mesothelioma cell line:Mero-41	10851-111F5	1589.33	1.47	2.69	3.42	2.93	3.67	0.98	0.73
mesothelioma cell line:Mero-48a	10852-111F6	1024.34	1.55	1.77	0.44	0.89	1.33	0.89	0.89
mesothelioma cell line:Mero-82	10853-111F7	1290.90	3.15	1.84	3.94	2.10	1.84	1.84	0.53
mesothelioma cell line:Mero-83	10854-111F8	1563.31	3.57	2.55	2.04	2.72	1.87	2.21	1.70
mesothelioma cell line:Mero-84	10855-111F9	1125.60	2.53	1.77	2.27	1.77	0.76	0.76	1.52
mesothelioma cell line:Mero-95	10856-111G1	1402.71	2.07	1.45	3.52	2.07	1.45	2.48	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	948.50	1.16	0.99	1.49	0.83	1.66	1.33	0.50
mesothelioma cell line:NCI-H226	10846-111E9	1496.80	2.53	2.35	3.80	1.63	1.09	2.17	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	1215.57	1.37	2.22	1.54	2.05	1.54	1.88	0.85
mesothelioma cell line:NCI-H28	10845-111E8	1254.01	3.56	2.04	2.29	2.80	3.56	2.54	2.29
mesothelioma cell line:No36	10857-111G2	1462.04	2.61	2.94	2.28	3.59	2.28	1.63	0.98
mesothelioma cell line:ONE58	10858-111G3	755.69	2.17	1.35	1.08	1.35	0.54	1.63	2.71
migratory langerhans cells, donor1	11901-125F2	784.20	0.58	0.77	0.77	0.77	0.38	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	607.77	0.49	0.73	0.37	0.49	0.37	0.12	0.37
migratory langerhans cells, donor3	11903-125F4	850.38	0.90	0.90	0.72	0.54	0.36	0.36	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	440.75	6.53	4.24	3.26	2.61	1.31	1.31	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	429.59	3.39	2.54	1.91	0.85	0.85	1.48	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	1041.45	1.84	1.15	0.69	1.38	1.61	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	1266.58	3.23	1.71	1.33	0.95	3.04	0.95	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	2748.05	4.44	3.14	3.51	3.14	2.40	0.74	2.59
myeloma cell line:PCM6	10474-106I6	2353.03	3.16	3.56	2.57	0.99	1.19	1.19	2.17
myxofibrosarcoma cell line:MFH-ino	10600-108E6	482.94	1.01	0.00	0.51	0.51	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	1055.23	2.75	1.96	0.59	1.18	0.78	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	1112.13	1.11	1.34	0.33	0.78	0.56	0.22	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	1110.31	1.47	1.10	0.66	0.81	0.96	0.37	0.59
nasal epithelial cells, donor2	12227-129F4	1214.93	2.76	2.21	1.10	1.10	0.00	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	3965.56	1.38	1.84	2.07	2.99	1.61	0.46	1.38
neuroblastoma cell line:NB-1	10539-107G8	1683.21	1.50	1.31	0.75	0.94	0.75	0.56	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	1239.60	1.69	3.37	1.48	1.48	1.05	1.05	0.84
neuroblastoma cell line:NH-12	10555-107I6	3790.19	3.54	6.15	4.10	1.49	1.68	1.68	2.24
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	1982.02	7.12	5.22	4.51	2.14	2.14	2.14	2.85
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	2059.74	8.39	5.23	4.28	4.91	3.17	3.01	2.38
neuroectodermal tumor cell line:TASK1	10774-110F9	4554.71	5.64	4.63	4.83	3.62	3.42	2.42	3.82
neuroepithelioma cell line:SK-N-MC	10728-110A8	1010.87	1.91	3.18	0.00	1.91	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	1074.51	0.80	1.60	0.53	1.86	1.86	0.27	0.27
neutrophil PMN, donor1	12133-128D9	431.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	172.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	492.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1810.60	2.54	1.18	1.01	1.01	1.35	1.18	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	543.54	0.00	0.80	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	1343.02	5.13	4.49	4.17	1.92	3.21	2.56	2.56
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	979.59	4.99	3.68	4.99	3.15	1.58	1.84	1.58
nucleus accumbens, adult, pool1	10037-101F1	1125.43	1.03	0.75	1.03	0.00	0.37	0.19	0.28
occipital cortex - adult, donor10196	10172-103C1	607.81	4.12	0.00	0.00	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	798.38	2.15	1.88	1.88	1.07	1.07	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	1691.97	2.55	2.91	1.09	1.09	3.28	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	1001.58	4.99	2.10	2.36	2.62	3.15	0.52	1.84
occipital lobe, fetal, donor1	10073-102A1	2091.01	12.87	3.43	6.01	4.72	3.00	2.15	1.72
occipital pole, adult, pool1	10036-101E9	1392.97	1.02	0.95	0.71	0.55	0.47	0.24	0.39
olfactory region, adult	10195-103E6	623.02	0.76	1.15	0.38	0.38	0.57	0.38	0.76
optic nerve, donor1	10277-104E7	552.29	0.00	8.00	2.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	1265.18	1.48	1.48	1.37	0.68	0.80	0.57	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1365.07	2.06	0.82	0.55	0.82	0.69	0.69	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	680.17	1.52	0.85	1.02	1.02	1.19	0.17	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	1367.16	2.43	1.73	2.31	0.81	0.58	1.04	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	1059.16	0.59	2.06	1.18	1.18	1.47	1.18	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1173.52	0.93	3.74	0.93	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	2017.53	2.97	0.64	0.64	1.27	1.06	0.00	1.70
ovary, adult, pool1	10020-101D2	2522.89	1.14	2.36	2.10	1.48	2.97	2.53	4.02
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	802.21	2.20	4.03	1.47	2.38	2.02	0.37	0.92
pancreas, adult, donor1	10049-101G4	5635.37	12.23	15.99	14.11	5.64	6.58	3.76	4.70
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1416.41	2.24	0.84	1.12	4.19	3.63	1.96	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	777.32	2.04	2.38	2.56	1.36	0.85	0.68	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	792.81	0.33	0.83	0.17	0.50	0.66	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	1149.70	0.82	0.92	0.82	0.82	0.64	0.55	0.18
parietal cortex, adult, donor10258	10373-105G4	685.56	0.00	0.73	0.00	0.73	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	576.52	1.88	2.82	0.00	0.94	1.88	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	800.38	3.42	3.42	3.42	1.14	0.57	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	1171.29	0.79	0.44	0.26	0.09	0.53	0.44	0.53
parietal lobe, fetal, donor1	10072-101I9	2054.11	8.73	3.88	4.85	3.88	3.88	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	1424.41	1.87	0.75	0.00	1.87	0.75	1.50	0.00
parotid gland, adult	10199-103F1	3801.73	4.32	3.70	6.78	3.08	0.62	3.08	1.85
penis, adult	10200-103F2	1602.21	5.37	9.13	4.83	2.15	4.83	4.30	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2277.53	4.83	5.02	3.90	2.97	5.02	1.49	2.97
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	852.31	1.89	0.87	1.02	0.58	0.44	0.73	0.58
pineal gland - adult, donor10196	10179-103C8	429.59	0.65	1.29	1.29	1.29	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	856.93	2.96	0.59	1.78	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	768.17	1.25	0.00	0.00	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	1145.36	5.06	2.02	1.01	5.06	2.02	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	1821.00	2.61	3.65	2.08	2.61	1.56	1.56	1.56
pituitary gland, adult, donor10258	10378-105G9	1814.00	1.70	1.70	0.85	0.85	0.00	0.85	2.55
placenta, adult, pool1	10021-101D3	926.46	1.18	0.43	1.40	1.08	0.11	0.75	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	1884.83	3.18	3.18	1.85	3.31	1.19	1.32	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	450.73	0.31	0.47	0.16	0.47	0.16	0.00	0.31
pons, adult, pool1	10033-101E6	824.18	0.69	1.20	0.43	0.26	0.60	0.17	0.09
postcentral gyrus, adult, pool1	10032-101E5	1358.11	1.13	1.57	0.78	0.70	0.26	0.52	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	1618.74	2.09	4.18	4.18	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	1388.03	5.51	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	1490.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	1314.89	2.77	2.91	2.04	1.60	0.73	1.75	0.87
prostate cancer cell line:PC-3	10439-106E7	663.21	1.45	0.18	0.54	0.54	0.73	0.18	0.36
prostate, adult, pool1	10022-101D4	1702.92	0.91	1.54	1.54	1.18	2.27	1.81	2.00
putamen, adult, donor10196	10176-103C5	808.99	1.18	0.71	0.71	0.71	0.47	0.00	0.47
putamen, adult, donor10252	10152-102I8	537.24	5.88	1.96	5.88	1.96	1.96	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	731.09	0.00	1.09	1.09	2.19	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	840.81	0.97	0.72	0.48	0.48	0.72	0.72	0.97
putamen, newborn, donor10223	10365-105F5	1614.02	0.75	1.50	0.75	0.75	1.50	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	875.42	1.16	1.16	0.29	1.16	0.29	0.29	0.58
rectum, fetal, donor1	10067-101I4	1812.46	6.95	4.17	4.17	4.17	4.17	4.17	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	693.02	1.06	0.85	1.70	0.00	0.00	0.64	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	302.79	1.66	0.83	0.83	0.41	0.00	0.41	0.41
retina, adult, pool1	10030-101E3	1361.97	1.79	1.69	0.60	0.70	0.50	0.30	0.60
retinoblastoma cell line:Y79	10475-106I7	4930.53	6.50	4.42	7.27	3.64	5.20	3.90	4.68
rhabdomyosarcoma cell line:KYM-1	10787-110H4	1073.22	1.23	0.98	0.49	1.60	1.23	0.12	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	1718.98	2.53	3.37	1.12	1.97	0.84	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	1179.22	3.03	6.82	1.52	0.00	0.76	0.00	1.52
salivary acinar cells, donor1	11771-123I7	2709.15	3.40	3.40	2.10	4.21	3.56	2.10	0.81
salivary acinar cells, donor2	11772-123I8	3498.22	6.61	4.82	4.54	4.96	7.71	3.17	1.93
salivary acinar cells, donor3	11773-123I9	1056.63	0.66	5.96	4.63	2.65	1.99	0.00	0.66
salivary gland, adult, pool1	10093-102C3	3396.25	2.29	6.29	0.57	2.86	1.72	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	1831.75	1.18	1.10	2.28	1.01	1.69	1.35	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	1608.46	2.23	1.41	0.47	0.59	1.65	0.82	0.59
seminal vesicle, adult	10201-103F3	960.26	11.11	14.81	8.99	2.65	3.17	5.29	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	633.30	3.64	2.19	1.46	1.46	0.73	0.97	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	1102.90	2.77	4.28	2.77	3.02	2.26	1.51	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	954.36	3.01	0.00	4.01	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	1366.04	1.61	2.96	2.28	1.07	0.67	0.81	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	731.58	0.99	0.44	0.33	0.66	0.55	0.11	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	1638.36	1.68	1.55	1.42	0.90	0.90	0.77	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	1051.23	7.09	8.51	2.84	2.13	2.84	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	3981.56	4.20	5.28	3.12	3.12	4.32	2.52	3.48
skeletal muscle, fetal, donor1	10066-101I3	3972.83	22.11	17.09	6.03	16.08	14.07	4.02	3.02
skin, adult, donor1	10074-102A2	1350.26	6.79	0.00	6.79	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	1613.42	13.89	1.89	5.05	6.31	5.68	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	1105.96	1.33	0.67	0.67	3.34	4.34	0.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1011.49	1.89	2.84	0.63	2.21	0.32	0.63	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	1767.11	3.08	3.85	3.28	3.85	3.08	0.96	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	1940.84	1.81	1.32	1.32	1.15	1.65	0.99	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2661.90	4.66	2.90	3.06	1.77	1.93	1.61	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	508.40	0.22	0.44	0.22	0.44	0.44	0.44	0.44
small intestine, adult, pool1	10024-101D6	1982.87	1.79	1.79	2.15	2.03	1.91	5.26	3.22
small intestine, fetal, donor1	10064-101I1	1597.52	5.65	4.18	3.93	1.97	1.72	1.72	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	646.26	4.62	4.10	4.62	1.54	0.00	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	1523.85	4.65	4.14	2.58	2.33	1.29	1.03	0.00
somatostatinoma cell line:QGP-1	10781-110G7	1369.32	2.41	2.68	1.34	1.61	2.68	0.27	1.07
spinal cord - adult, donor10196	10181-103D1	495.29	2.98	1.15	0.46	1.15	2.29	1.38	0.23
spinal cord, adult, donor10252	10159-103A6	697.47	1.58	0.00	0.00	0.79	0.00	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	584.57	1.38	0.69	0.69	0.69	0.00	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	1234.92	3.66	4.27	3.05	1.83	1.22	3.05	0.61
spinal cord, newborn, donor10223	10359-105E8	1156.30	0.92	2.30	2.76	2.30	3.21	1.38	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	866.40	1.94	1.49	0.90	1.34	0.90	0.30	0.30
spleen, adult, pool1	10025-101D7	1286.15	0.88	0.33	1.32	1.10	1.32	1.76	1.32
spleen, fetal, pool1	10044-101F8	1440.92	1.19	1.19	0.95	0.64	0.48	0.48	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1333.86	1.86	1.45	0.93	1.24	0.31	0.31	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1000.08	1.14	2.09	0.76	1.71	0.19	0.19	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	959.25	3.49	4.89	3.15	0.70	1.40	1.40	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	1783.82	3.91	3.13	2.35	3.91	3.13	0.39	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1128.52	1.13	0.34	0.68	0.56	0.45	0.23	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1157.28	2.12	1.69	1.27	2.97	2.12	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	708.64	0.85	0.00	0.00	1.69	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	582.05	4.27	3.20	0.00	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	1964.26	7.41	10.82	7.41	3.42	2.85	1.71	1.14
substantia nigra - adult, donor10196	10178-103C7	434.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	692.28	2.91	0.62	0.83	0.62	0.83	0.62	0.42
substantia nigra, adult, donor10258	10371-105G2	612.42	0.52	1.55	0.00	0.52	0.00	1.03	1.03
substantia nigra, newborn, donor10223	10358-105E7	951.05	0.71	0.71	0.00	0.71	0.00	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	1519.80	2.06	1.83	1.15	2.29	1.15	1.38	0.69
temporal lobe, adult, pool1	10031-101E4	1390.49	1.02	0.85	1.02	0.68	0.76	0.76	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2265.72	17.09	7.83	12.11	4.27	4.27	7.12	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	2245.60	10.55	7.91	7.91	6.59	4.83	4.40	0.88
tenocyte, donor1	11763-123H8	1419.44	6.28	5.24	5.93	1.05	2.44	1.40	0.70
tenocyte, donor2	11765-123I1	1260.88	2.29	3.82	5.34	1.14	2.29	3.05	0.38
tenocyte, donor3	11768-123I4	1069.74	1.48	2.97	7.41	1.11	1.11	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1470.84	3.74	1.53	2.21	2.89	1.87	1.02	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	1543.49	3.70	2.93	1.85	1.54	2.31	2.31	2.77
teratocarcinoma cell line:PA-1	10807-111A6	1995.96	2.01	2.32	1.70	3.10	3.25	1.24	2.01
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1436.79	2.54	1.40	1.14	2.41	4.57	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1322.85	1.89	1.89	1.89	0.38	2.27	0.76	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2564.28	2.40	3.71	1.53	2.84	4.36	1.09	2.18
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1552.63	2.93	3.26	3.26	4.89	4.89	2.28	1.63
testis, adult, pool1	10026-101D8	1806.01	1.93	3.97	1.50	1.07	1.83	2.79	12.67
testis, adult, pool2	10096-102C6	1825.09	4.96	3.61	4.96	2.71	3.16	3.61	1.35
thalamus - adult, donor10196	10168-103B6	521.08	3.31	0.00	0.00	0.00	0.00	0.00	2.21
thalamus, adult, donor10252	10154-103A1	679.83	1.25	1.25	1.25	0.31	0.63	0.31	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	329.48	0.00	1.54	0.00	0.00	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	456.19	1.48	2.64	1.65	0.66	0.82	1.15	0.66
thalamus, newborn, donor10223	10366-105F6	778.41	1.15	0.00	1.15	1.73	1.73	0.00	0.00
throat, adult	10209-103G2	1540.96	2.50	3.99	4.74	1.00	3.99	1.00	2.25
throat, fetal, donor1	10061-101H7	1392.81	3.96	2.44	2.13	3.05	1.22	1.52	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	3292.39	2.58	3.58	3.58	4.17	1.99	1.99	2.19
thymus, adult, pool1	10027-101D9	2070.81	1.89	1.59	1.69	1.19	1.89	3.18	3.28
thymus, fetal, pool1	10043-101F7	1462.87	0.52	1.56	0.62	1.14	1.04	1.35	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	1092.80	2.39	1.20	0.80	2.13	1.06	0.80	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	2135.87	3.63	4.05	2.65	2.93	2.37	1.12	1.54
thyroid, adult, pool1	10028-101E1	2259.57	2.89	2.80	1.40	1.31	2.71	2.71	2.33
thyroid, fetal, donor1	10060-101H6	1203.62	5.80	1.05	2.11	1.32	0.79	1.32	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	699.07	0.00	0.00	3.08	0.00	6.16	0.00	0.00
tongue, adult	10203-103F5	1547.34	3.49	8.14	5.81	1.86	4.65	2.09	0.93
tongue, fetal, donor1	10059-101H5	1366.71	3.94	2.36	4.34	1.58	1.58	1.18	0.79
tonsil, adult, pool1	10047-101G2	2077.84	1.30	1.30	1.30	1.40	0.90	0.50	0.50
trachea, adult, pool1	10029-101E2	1631.80	1.80	2.29	1.31	0.49	1.64	1.23	1.80
trachea, fetal, donor1	10058-101H4	1522.24	5.77	5.00	3.08	3.08	2.31	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	1312.59	2.13	1.06	0.00	0.71	1.42	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	1030.79	0.81	1.32	0.71	0.71	0.41	0.20	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	2102.11	3.60	3.92	2.51	2.35	3.13	1.25	2.51
tridermal teratoma cell line:HGRT	10694-109G1	513.68	0.00	1.90	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	2028.48	2.96	1.27	1.69	1.95	2.20	1.10	0.93
umbilical cord, fetal, donor1	10057-101H3	1266.51	8.35	6.26	2.09	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	2018.53	0.85	1.54	1.37	0.68	1.19	1.71	1.37
uterus, fetal, donor1	10055-101H1	1809.67	2.56	3.07	3.58	1.02	1.02	1.02	0.51
vagina, adult	10204-103F6	1305.97	2.58	1.29	0.65	1.29	3.23	1.94	0.00
vein, adult	10191-103E2	1356.18	3.07	3.95	1.75	2.41	0.88	2.41	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1717.05	2.67	2.40	2.94	2.40	1.87	1.34	1.34